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ABSTRACT
GENE EXPRESSION ANALYSIS OF NEUROTROPHINS, TRK
RECEPTORS, AND ASSOCIATED REGULATORY MOLECULES
AFTER CONTUSIVE SPINAL CORD INJURY
Matthew Tyler Hougland
August 12, 2013

Traumatic spinal cord injury (SCI) results in changes to the anatomical,
neurochemical, and physiological properties of cells in the central and peripheral nervous
system. Neurotrophins, acting by binding to their cognate Trk receptors on target cell
membranes, contribute to modulation of anatomical, neurochemical, and physiological
properties of neurons in sensorimotor circuits in both the intact and injured spinal cord.
Neurotrophin signaling is associated with many post-SCI changes including maladaptive
plasticity leading to pain and autonomic dysreflexia, but also therapeutic approaches such
as training-induced locomotor improvement. Here we characterize expression of mRNA
for neurotrophins and Trk receptors in lumbar dorsal root ganglia (DRG) and spinal cord
after two different severities of mid-thoracic injury and at 6 and 12 weeks post-SCI.
There was complex regulation that differed with tissue, injury severity, and survival time,
including reversals of regulation between 6 and 12 weeks, and the data suggest that
natural regulation of neurotrophins in the spinal cord may continue for months after birth.
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Our assessments determined that a coordination of gene expression emerged at the 12
week post-SCI time point and bioinformatic analyses address possible mechanisms.
Additionally, we sought to determine if the regulatory patterns we observed were perhaps
due to an inflammatory molecule that mediated the coordinated expression pattern that
we observed at 12 weeks post injury, and identified the chemokine CCL2 as a potential
candidate gene.
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CHAPTER 1
GENERAL INTRODUCTION
1.1 Spinal cord injury
Estimates of the global occurrence of spinal cord injuries (SCI) are in the range of
100000 to 300000 new cases reported each year (Barbeau H 1999). Many factors
contribute to the spontaneous recovery (or lack thereof) observed in patients with SCI as
a result of changes in the injured spinal cord, with many functional aspects of daily life
being negatively affected. In particular, locomotion is among the most common and
debilitating of these. Limited independent mobility is associated with lower life
satisfaction and quality of life post-SCI, and enhancing sensory and locomotor capability
of patients with SCI has a dramatically positive effect (Putzke JD 2002).
Traumatic injury to the spinal cord results in a variety of changes not only to
neurons within the spinal cord but throughout the entire sensorimotor circuitry. Sensory
neurons of the dorsal root ganglia (DRG) rapidly undergo long-lasting changes in their
electrophysiological properties and growth capacity (Bedi SS 2010; Bedi SS 2012;
Walters 2012). Locomotor circuitry in the spinal cord caudal to an injury site undergoes
plasticity at the cellular, synaptic, and connectivity levels in an activity dependent manner
after injury in humans and experimental models (Edgerton VR 2004; Rossignol S 2006;
Petruska JC 2007). One strategy to restore function after spinal cord injury (SCI) is
physical therapy and/or locomotor rehabilitation training (Wernig A 1995).
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1.2 Locomotor rehabilitation training and activity dependent plasticity
Factors that determine the functional outcome after training include both
the severity and location of the injury. Based on these factors, some patients with
incomplete SCI can improve walking ability after rehabilitation training (Wernig A
1995). A similar degree of improvement has not been shown in motor complete injuries,
but several weeks of treadmill training can increase the load bearing capacity of clinically
complete patients (Dietz V 1995). These changes can partially be attributed to a
reorganization of sensorimotor circuits. For example, (Grasso R 2004) showed that in
ASIA A/B patients (complete motor loss) and ASIA C/D patients (incomplete motor loss)
with body weight supported treadmill training (BWST), levels of activation of motor
neuron pools show drastic spatiotemporal changes when compared with controls (healthy
subjects) (Figure 1), though foot placement was roughly equal between all groups. These
and other studies (Beres-Jones JA 2004, Ivanenko YP 2003, for review see Dietz V 2002)
highlight the ability of the injured human spinal cord to produce rhythmic patterns that
are modulated with training.
A degree of locomotor capability can also be restored after training in animal
models. After transection, cats trained to perform bipedal stepping of the hindlimbs
improve on the basis of two behavioral criteria. Trained cats step at speeds six times
faster and can produce 30-50 more successful steps during an evaluation session than
non-trained cats. (Figure 2) During the swing phase, electromyography (EMG) burst
amplitude increased in the tibialis anterior (TA, an ankle flexor) and decreased in the
vastus lateralis (VL, a knee extensor) and medial gastrocnemius (MG, an ankle extensor),
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similar to what is seen in uninjured cats. This finding is consistent with evidence in
humans that shows after treadmill training, EMG amplitude in the MG is increased
during the stance phase, and improper co-activation of the TA during the stance phase is
decreased (Dietz V 1995). The differences seen in EMG activity were also reflected by
differences in kinematics; vertical displacement of the ankle was higher in the steptrained cats, at the end of stance the hindlimbs extended further, and the swing phase
projected further forward at placement in the trained versus untrained cats (de Leon RD
1998). When stand training is provided to transected adult cats for 12 weeks, the load
bearing capacity of the hindlimbs increased. At the end of the 12 week training period,
cats that received stand training were able to maintain full weight-bearing hindlimb
extension for an average 545 s longer than cats that were untrained. Longer periods of
standing are indicative of an enhanced ability to activate hindlimb extensors and thus
maintain load-bearing extension at the knee and ankle joints. To test whether the
characteristics of stepping were retained when the task is no longer practiced, EMG
amplitude and kinematic assessments were done 6 and 12 weeks after the cessation of
training. After 6 weeks, the hindlimb circuitry retained the characteristic patterns that
were seen at the cessation of training, however by 12 weeks these acquired characteristics
were lost. Despite this lack of task specific retention, when the animals were re-trained
after the 12 week period, they acquired the ability to stand four times faster than with
initial training (De Leon RD 1999).
Further evidence for reorganization of the sensorimotor circuitry after injury
comes from rat models. In adult rats after contusion injury, treadmill training leads to
restoration of kinematic stepping parameters seen in the normal state (Heng C 2009).
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Treadmill training can not only compensate for the decrease elicited by a neonatal
transection(assessments done in adult rats), but results in larger than normal EPSPs(a
measure of the synaptic input onto a motoneuron), and reverses the SCI induced increase
in AHP depth(part of what determines firing frequency of a neuron based on a given
input current) (Petruska JC 2007). In the same model, step training enhanced the
locomotor capability of rats, and this enhancement was not due to regrowth of either
ascending or descending axons across the site of the lesion (Tillakaratne NJ 2010).
In the isolated lumbar spinal cord, reorganization of sensorimotor circuits
can essentially occur in either the afferent neurons (DRG), interneurons in the spinal
cord, or the motor neurons themselves (as mentioned above). Monosynaptic connections
are made onto interneurons that project both ipsilaterally and contralaterally from group
Ib and II afferents (Jankowska E 2009), and are important for the pattern generating
characteristics of sensorimotor circuitry. These interneurons reside within laminae VVIII and can be glutamatergic, glycinergic, or GABA/glycinergic (Bannatyne BA 2009).
Following injection of the glycinergic inhibitor strychnine, transected adult cats were
trained to either step or stand for twelve weeks, and stepping ability was then assessed
after thirty minutes. The cats trained to step showed no difference in stepping ability
before or after administration of strychnine, however the cats that were trained to stand
were not initially able to step, but after injection were able to regain full weight-bearing
stepping. The group of cats that were trained to step for the first twelve week period,
were then re-trained to stand for twelve weeks and likewise the cats that were initially
trained to stand were then re-trained to step for twelve weeks. Following this additional
twelve weeks of training, the cats re-trained to stand (that were first trained to step)
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showed similar results to the initial twelve week stand trained group in that they were not
able to step initially but regained the ability after administration of strychnine. Similarly,
the cats that were re-trained to step for twelve weeks lost their responsiveness to
strychnine with results analogous to the step trained group after the first twelve weeks (de
Leon RD 1999). Collectively, these studies demonstrate the potential for sensorimotor
circuits in the lumbosacral spinal cord to develop and retain physiological information in
an activity dependant manner after training.

1.3 Neurotrophins, Trk receptors and SCI
The neurotrophins Nerve Growth Factor (NGF), Brain Derived Neurotrophic
Factor (BDNF), and Neurotrophin 3 (NT3) are secreted growth factors that were first
characterized for their important role in the survival of subpopulations of sensory neurons
and in formation of spinal cord sensorimotor circuits during development (Barbacid M
1995; Lindsay RM 1996; Huang EJ 2001). In addition to these essential roles in
establishing the physiological patterns of developing neural circuitry, neurotrophins are
implicated as having a role in activity dependent changes associated with restoration of
function after spinal cord injury.
When uninjured rats are trained for five days and sacrificed at different time
points after training, BDNF levels increase two hours post training in the spinal cord and
at all time points in the soleus muscle. NT3 showes a similar expression pattern to
BDNF, with elevated levels two and six hours after training in the cord and at all time
points in soleus muscle (Gomez-Pinilla, 2001). NT3 and its high affinity receptor TrkC
were further analyzed at three and seven days after voluntary wheel running. NT3
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mRNA and protein levels in the lumbar spinal cord were elevated both three and seven
days after voluntary exercise. In the soleus muscle, NT3 mRNA and protein levels were
elevated at all points. TrkC mRNA was elevated in the cord significantly at both time
points, and protein after three days (Ying Z 2003). These studies suggest a similar
pattern of regulation for the neurotrophins in the uninjured cord, but also provide a basis
for how their regulation changes after injury.
Using spinal isolation (SI), which eliminates all supraspinal and afferent input to
lumbar spinal cord, both NT3 and BDNF were down-regulated in the lumbar region
bereft of input. In the same study, when botulinum toxin was injected unilaterally into
the muscle, eliminating efferent output to the ipsilateral muscle but leaving the sensory
input intact, NT3 expression was increased in the ipsilateral hemicord compared to the
contralateral hemicord, while BDNF was decreased (Gómez-Pinilla F 2004). In the
lumbar cord after hemisection, rats were placed in either a trained group or sedentary
group and their levels of neurotrophins were analyzed at several time points. BDNF
levels of trained rats decreased after injury and were restored after training, while NT3
stayed the same as controls after injury and with training expression levels were
significantly elevated after 28 days (Ying Z 2005).
Rats with a moderate mid-thoracic contusion subjected to three different types of
exercise (treadmill, stand, and swim) show altered expression levels of the neurotrophins
BDNF and NT3 in both the spinal cord and soleus muscle (ankle extensor). As seen with
hemisection, BDNF expression in the cord decreased after injury, but all forms of
exercise restored expression to levels seen in controls. In the soleus muscle, only the
group with treadmill training returned to pre-injury levels. Levels of NT3 expression
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were elevated in both the cord and soleus muscle with all the exercise regimes (Figure 3)
(Hutchinson KJ 2004). Delivery of exogenous BDNF and NT3 to the transected spinal
cord improves recovery of hindlimb function (Blits B 2003)(in rats) and results in a level
of function similar to that seen in animals receiving locomotor training after spinal
transection (Figure 4) (Boyce VS 2007)(in cats). In light of the demonstrated and
suggested roles in modulating sensorimotor physiology, characterizing the endogenous
regulation of neurotrophins and their receptors after injury is particularly relevant.

1.4 Neurotrophins and Physiology
Neurotrophins have key roles in modulating the anatomical,
neurochemical, and physiological properties of cells in the central and peripheral nervous
system. The effects of neurotrophins on responses to stimuli in both the intact and
injured nervous system have been extensively investigated and studies have demonstrated
an important role in modulation of sensorimotor physiology (Huang EJ 2001; Huang EJ
2003; Reichardt LF 2006; Skaper SD 2008; Skaper SD 2012). The neurotrophins have
therefore become a frequent target for manipulation after injury.
Physiological and behavioral studies have established NGF as a nociceptive
agonist. NGF administration to neonatal, juvenile, and adult rats over the course of 9
weeks results in a decrease in both mechanical and thermal withdraw latency, indicated
hypersensitivity to both types of stimuli (Lewin GR et al. 1993). These findings are also
extended to the single cell level, evident by the finding that nociceptive DRG neurons
responsive to capsaicin are sensitized upon application of NGF (Shu and Mendell 2001).
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After subcutaneous injection of BDNF and NT3 into neonatal rats, an
enhancement in the response of motoneurons to increasing intensities of dorsal root
stimulation after BDNF was seen in the polysynaptic component, whereas no change is
observed in the monosynaptic component. In contrast, after NT3 injection, the
monosynaptic component showed the greatest increase, with an increase in the
polysynaptic component also observed to a lesser degree. Additionally, four treatments
were administered; BDNF, TrkB-IgG (blocks BDNF signaling), NT3, and TrkC-IgG
(blocks NT3 signaling). TrkB-IgG and NT3 both increased the average amplitude of the
EPSP, while TrkC-IgG and BDNF had the opposite effect (Figure 5) (Seebach BS 1999).
These results indicate that the levels of these neurotrophins have potentially different
effects following postnatal injection, in that NT3 potentiates the monosynaptic
component of the EPSP and to a lesser degree the polysynaptic component, while BDNF
enhances the exclusively the polysynaptic component.
These results are also consistent with the notion that TrkB activation has an effect
on plasticity through facilitation of GABAergic transmission (i.e. interneuron) (Pezet S
2002), TrkB ligands have a suppressive effect on mechanosensory plasticity in the
deafferented spinal cord (Ramer LM 2007), and have been shown to hypersensitize
neurons of the superficial dorsal horn receiving high threshold primary afferent input
(Garraway SM 2003), highlighting the broad physiological role of TrkB ligands in the
function of the nervous system.
When the distal stump of the MG nerve in axotomized cats is placed in NT3, they
exhibit Ia EPSPs 2.5 times normal, and 5 times larger than the axotomized that are left
untreated. Conduction velocity of group I afferents in treated animals recovered to
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normal values (Munson JB 1997). Removal of NT3 four to five weeks later results in a
subsequent decline in both EPSP and conduction velocity within one week to values
observed in the axotomized group, while NT4/5 (a TrkB ligand) causes a limited
improvement in conduction velocity with no effect seen in the EPSP (Mendell LM 1999).
This is also the case for chronic application of NT3, as fibroblast implants into the
lumbosacral cord enhanced the EPSP from both central and segmental inputs (Arvanian
VL 2003). Additionally, cultered dorsal root ganglion cells allowed to grow in BDNF
and NT3 conditioned media from AAV infected HEK cells exhibit robust neurite
outgrowth (Blits B 2003).Taken together, these studies suggest that neurotrophins can
support both anatomical and physiological forms of plasticity

1.5 Neurotrophins/Trks expression in sensorimotor circuits after injury
Neurotrophins influence cellular processes by binding to membrane-bound
receptors which transduce the extracellular signal into intracellular effect – their high
affinity tyrosine kinase receptors. In general, NGF binds TrkA, BDNF binds TrkB, and
NT3 binds TrkC (Barbacid M 1995; Patapoutian A 2001; Huang EJ 2003), although
cross-talk is recognized and there is a low-affinity pan-neurotrophin receptor p75, which
we do not consider here. To determine the role of neurotrophins in any process or
condition one must examine not only the neurotrophins, but also the receptors.
Prior characterizations of changes in neurotrophins and Trk receptors in lumbar
neural circuitry have been instrumental in elucidating the complex regulation of these
important molecules after injury (Table 1). However, these have largely focused on time
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points of less than 6 weeks (Hayashi M 2000; Liebl, Huang et al. 2001; Liebl DJ 2001;
Nakamura M 2001; Widenfalk J 2001; Qiao and Vizzard 2002; Qiao L 2002; Gulino R
2004; Zvarova, Murray et al. 2004; Qiao and Vizzard 2005; Qiao LY 2005; Qian DX
2006; Li XL 2007; Hajebrahimi, Mowla et al. 2008; Hajebrahimi Z 2008; Qian, Zhang et
al. 2011; Qian DX 2011; Keeler BE 2012). Although valuable for elucidating the role of
neurotrophin signaling in the first 6 weeks after SCI, these data are of uncertain value for
relating to longer-term post-SCI function. Given the many demonstrations of continued
changing conditions after SCI (Beattie, Hermann et al. 2002; Profyris, Cheema et al.
2004; Ung, Lapointe et al. 2008; Beck, Nguyen et al. 2010), it is important to recognize
that the temporal character of experiments has a significant influence on the outcome.

1.6 Inflammation and SCI
Another important aspect of SCI that affects cellular processes and influences
how the nervous system responds to injury is inflammation. In humans after SCI,
neutrophils, macrophages, and lymphocytes enter the cord through hemorrhage or
extravasation, inducing a robust microglial response (Fleming, Norenberg et al. 2006).
This cellular infiltration acutely after traumatic injury results in an upregulation of
inflammatory factors in endogenous cells of the nervous system (neurons and microglia)
such as IL1beta, IL6, and TNFalpha (Yang, Blumbergs et al. 2004). In rats, early
transient increases in IL1beta, IL6 and TNFalpha are injury severity dependent, and as is
the case in humans, is a result of upregulation of expression in neurons and microglia, not
blood borne leukocytes (Yang, Jones et al. 2005). The acute early release of these
cytokines leads to induction of their mRNA, as mice lacking the receptors for TNFalpha
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and IL1 exhibit a diminished level of expression of these molecules (Pan, Ni et al. 2002).
However, this expression pattern is transient, and returns quickly to levels seen in
controls (Streit, Semple-Rowland et al. 1998).
In addition to these cytokines, many others have been identified as being
upregulated after SCI in rodents such as IL-6, IL-1α, IL-1β, IL-13, CCL2, MIP1α,
RANTES, and TNFα (Stammers, Liu et al. 2012). This finding can be extended to
humans in the case of IL-6, IL-8, and CCL2, and has even been suggested as being a
relevant biomarker for injury severity and subsequent recovery, as they were able to
better predict the outcome of motor recovery 6 months after injury than the ASIA score
(Kwon, Stammers et al. 2010). CCL2 has been shown to be upregulated in many models
of peripheral nerve injury, and has a role in the development of pain after peripheral
nerve injury (Tanaka, Minami et al. 2004; Jeon, Lee et al. 2008; Bhangoo, Ripsch et al.
2009; Jeon, Lee et al. 2009; Foster, Jung et al. 2011). Similar to IL1beta, induction of
CCL2 expression can be accomplished through the actions of TNFalpha (Jeon, Sung et
al. 2011). TNFalpha has also been shown to lead to hyperalgesia in models of peripheral
inflammation, through regulation of both NGF (Woolf, Allchorne et al. 1997) and
BDNF-TrkB (Lin, Ro et al. 2011). Thus, in studies investigating SCI and neurotrophin
regulation, examination of cytokines and other markers of inflammation could prove to
be instrumental in uncovering novel interactions that govern expression of plasticity
related molecules.
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CHAPTER 2
MATERIALS AND METHODS

2. Materials and methods
All experimental protocols and procedures were approved by the Institutional Animal
Care and Use Committee at the University of Louisville, Louisville, KY. Experimental
animals were 7 week old female Sprague–Dawley rats (Taconic Labs, Hudson, New
York). Animals were housed in pairs throughout the course of our experiments.

2.1 Surgical spinal cord injury
Rats (n = 47) were anesthetized with 50mg/kg sodium pentobarbital (Sigma, St Louis,
MO). Once sedated, Lacquer Lube was applied to the eyes to prevent drying. After skin
incision, laminectomy was performed at vertebral level T9, to expose the T10 spinal cord.
Contusion injuries were produced using the New York University (NYU) Impactor.
Either “Moderate” or “Moderately severe” injuries were produced by releasing a 10g,
2mm rod from 12.5 mm or 25 mm height, respectively, onto the exposed dura mater of
the spinal cord. These will subsequently be referred to as 12.5gcm and 25 gcm injuries.
Immediately after producing the contusion the wound was closed in layers and the skin
incisions were stapled. Rats received fluids (10cc 0.9% saline subcutaneously), and
antibiotic treatment (0.1cc Gentamicin (50mg/mL) intramuscularly, and Bacitracin was
topically applied on the incision site). Animals were housed overnight in a recovery
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room with a heating pad under their cage, and were taken to the animal facilities in the
morning.

Assessment of mRNA expression in SCI animals was compared to control animals.
These consisted of naïve rats (2 per time point group) and rats receiving laminectomy
only (3 rats per time point group), for a total of 5 controls per time point. There were 4
additional laminectomy-only control rats included with the animals used for the 6 week
post-SCI DRG assessment. All surgical procedures (except for the spinal cord injury),
were as described above for the laminectomy-only control rats.

2.2 Injury Characterization
2.2.1. Behavior
Experiments were performed on rats separated into groups based on injury severity,
survival time, and the tissue to be analyzed for mRNA expression. Rats were
familiarized with the testing procedures and personnel by handling for 1 week before
injury. Pre-surgical behavioral assessments were done to ensure no pre-existing
conditions were present that would subsequently affect our locomotor outcome measures.
Seventeen rats received 12.5g-cm NYU (moderate) and sixteen rats received 25 g-cm
NYU (moderately severe) injuries. Hindlimb locomotor function was assessed with the
Basso, Beattie, and Bresnahan Locomotor Rating Scale (BBB) (Basso DM 1996). BBB
testing was carried out prior to injury and 7, 14, 21, 28, 35, 42 for the six week spinal
cord group, and 7, 14, 21, 28, 35, 42, 49, 56, 63, 72, 79, and 84 days post injury for the
twelve week spinal cord (SC) groups, twelve week dorsal root ganglia (DRG) group, and
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at 7, 14, 28, and 42 days post injury for the six week DRG group. For testing, rats were
placed in an open field (a plastic tank that was 105 cm in diameter with 30 cm high walls)
for 4 min. BBB testing was done after animal care in the morning. Hindlimb movement
and locomotion were scored simultaneously by two observers who were blind to the
treatment groups. We include the BBB measures as a means to characterize the injuries
with commonly used assessments so that the mRNA measures can be placed in context.

2.2.2. Histology
At the end of the testing period, rats were anesthetized with sodium pentobarbital and
euthanized via transcardial perfusion with 30% RNA Later (Qiagen) in 0.1M Phosphate
Buffered Saline (PBS). An approximately 10 mm long block of spinal cord containing the
injury epicenter was removed from each animal and immersed in 4% paraformaldehyde.
After 1 week cords were immersed in PBS containing 30% sucrose for cryoprotection
until further processing. For sectioning, tissue was embedded in TissueTek® (VWR) and
frozen. The blocks were cut 50um thick in the transverse plane on a cryostat and were
sampled every 250μm. A series of sections spanning the rostrocaudal extent of the lesion
was stained with eriochrome cyanine (EC) to assess amounts of spared myelin as
described (Rabchevsky AG 2007) . Light microscopy was used to determine spared
white matter. Images were captured using a SPOT digital camera (Diagnostic
Instruments) mounted on a Zeiss Axioskop. From these, the area of spared tissue was
manually designated (Intuos drawing tablet; Wacom (Otone, Japan)). Areas of white
matter sparing were calculated using the ImageJ program and expressed as a proportion
of control (defined as group-mean of the smallest white matter area from an analogous
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section of spinal cord from all control animals). For each injured animal, the spinal cord
injury epicenter was defined quantitatively as the section containing the least amount of
intact tissue. Percent white matter sparing is reported as mean (± standard deviation). As
with the BBB, we include the WMS measures as a means to characterize the injuries with
commonly used assessments so that the mRNA measures can be placed in context.

2.3. mRNA expression

2.3.1. Isolation and cDNA conversion

Animals were euthanized after final behavioral assessments and exsanguinated by
transcardial perfusion using 30% RNA later (Qiagen) in Phosphate Buffered Saline
(PBS). Lumbar spinal cords (L4/5) and Dorsal Root Ganglia (DRG) were removed and
immersed in 100% RNA later and stored at -20°C until further processing. Spinal cords
were homogenized on ice in 1mL Trizol and RNA was isolated using Trizol/chloroform
extraction method. Briefly, homogenate was transferred to a 1.5mL tube and spun at
12000g for 10 min at 2°C. The supernatant was transferred to a new tube and 200uL
chloroform added. This mixture was spun for 15 min at 2°C to separate into aqueous and
organic phases. The aqueous phase was transferred to a new tube and alcohol
precipitation was performed with 100% isopropanol, then 70% ethanol. After removal
and drying of excess ethanol, the pellet was resuspended in 30uL nuclease free H20,
solubilized in 600uL Buffer RLT with beta-Mercaptoethanol (BME) and processed
through RNeasy MiniKit (Qiagen) per manufacturers protocol. DRGs were homogenized
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directly in Buffer RLT + BME and processed through RNeasy MiniKit. RNA was
analyzed by Nanodrop (ThermoScientific, Waltham, MA, USA) to obtain concentration
and 500ng of RNA from each sample was reverse transcribed into cDNA using Quanta
Biosciences qScript cDNA SuperMix. All RNA was converted to cDNA using the same
lot of reverse transcriptase. Performing the reverse-transcription for all samples with the
same reagents is a methodological procedure meant to reduce the cross-sample variability
which in turn can enhance the reliability of statistical assessments.

2.3.2. qRT-PCR

mRNA expression levels were quantified by qRT-PCR on Corbett Research 6000
(Qiagen) using FastStart Universal SYBR Green Master Mix(Roche). Duplicate reactions
were run for each sample for both the gene of interest and the normalizer (Beta-3 Tubulin
– demonstrated as a suitable normalizer gene for SCI work (Strube C 2008). Relative
expression levels were calculated as ∆∆CT of gene of interest vs. normalizer. Primer
sequences for the genes analyzed are provided in Table 2, along with their relationship to
the known gene structure and transcript species.

2.4. Statistics

Statistical analyses were performed using SPSS (IBM, North Castle, NY, USA) or
SigmaPlot/SigmaStat (Systat Software, San Jose, CA, USA). A Student’s t-test was
performed to determine if expression levels differed between control groups. In cases
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where gene expression did not differ between control groups the six and twelve week
control groups were combined and the expression values for the experimental groups are
reported as a fold change of the unified control group. One-way analysis of variance
(ANOVA) was performed on these values with post-hoc Tukey’s test for all pairwise
comparisons. All groups with p<0.05 difference are reported as significant. Pearson
Product Moment was calculated to determine the relationships between the expression
levels of the different transcripts, and to determine the relationships between BBB/WMS
vs. expression levels. Differences between BBB scores were assessed using a mixed
model repeated measures ANOVA with a post-hoc Bonferroni t-test.
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CHAPTER 3
EXPRESSION OF NEUROTROPHINS AND TRK RECEPTORS IN
SENSORIMOTOR CIRCUITS AFTER DIFFERING CONTUSION SEVERITIES

3.1 Introduction
The impact of SCI varies depending on the location of the injury itself and the
spatial relation of the investigated tissue to the SCI. The relative composition of types of
tissues innervated changes throughout the course of the neuraxis as does the specific
function of local circuitry. For example, in rat, the spinal components of bladder control
are focussed on the T13/L1 and L6/S1 segments, colon function is focused in L6/S1, and
the locomotor central pattern generator appears focussed in (though not limited to) the
L1/2 segments, spinal sympathetic circuitry regulating outflow exists roughly from T1L2, and spinal parasympathetic circuitry exists in the sacral-caudal spinal cord. Thus it
follows that the effect on spared function and/or recovery is influenced by the level of the
injury (Magnuson, Trinder et al. 1999; Magnuson, Lovett et al. 2005; Garcia-Alias,
Valero-Cabre et al. 2006), but this also extends to less direct functions (Campagnolo,
Bartlett et al. 2000; Lucin, Sanders et al. 2007). It is also very important to consider that
both neural and non-neural tissues remote from the SCI can be affected (Collazos-Castro,
Soto et al. 2005; Massey, Hubscher et al. 2006; Gris, Hamilton et al. 2008).
Sensory input to the spinal cord plays a role in establishing recovery and
regulating spinal function after alteration of descending inputs. For example, urinary
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bladder function after SCI is highly reliant on afferent input and plasticity of sensory
components (Tai, Roppolo et al. 2006; de Groat and Yoshimura 2009), and SCI affects
the trk receptor profile of neurons in DRG segments innervating bladder differently than
for DRG innervating hindlimb (Qiao and Vizzard 2002; Qiao and Vizzard 2005), a
finding that extends to spinal trk receptors as well (Zvarova, Murray et al. 2004).
Additionally, the type and amount of sensory input can influence spontaneous recovery
after SCI (Grau, Washburn et al. 2004; Ollivier-Lanvin, Keeler et al. 2010; Caudle,
Brown et al. 2011; Ferguson, Huie et al. 2012; Ferguson, Huie et al. 2012; Grau, Huie et
al. 2012) and also influence the effectiveness of physical therapy (Bouyer and Rossignol
1998; Bouyer and Rossignol 2003; Edgerton VR 2004; Gomez-Pinilla, Ying et al. 2004;
Edgerton, Courtine et al. 2008; Frigon and Rossignol 2009; Ollivier-Lanvin, Keeler et al.
2010), all of which may involve neurotrophin signaling (Gomez-Pinilla, Ying et al. 2004;
Hutchinson, Gomez-Pinilla et al. 2004; Boyce, Tumolo et al. 2007; de Leon 2007; Côté
MP 2011; Boyce, Park et al. 2012). Further, autonomic dysreflexia (AD), a maladaptive
condition frequently observed in patients with cervical or high thoracic SCI, is often
triggered by nociceptive sensory input (Maiorov, Fehlings et al. 1998; Krassioukov and
Fehlings 1999; Garstang and Miller-Smith 2007), and sprouting of central terminals of
nociceptive neurons, thought to be NGF-dependent, is a proposed mechanism that
contributes to AD (Weaver, Cassam et al. 1997; Krenz, Meakin et al. 1999; Marsh, Wong
et al. 2002; Cameron, Smith et al. 2006; Ackery, Norenberg et al. 2007).
Hence, it is important to examine not only the spinal cord, but also the sensory
neurons that provide signals to the spinal cord, and to consider that the effects of SCI on
the afferent neurons may differ in relation to the SCI, and/or to the tissues they innervate
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(Qiao and Vizzard 2002; Zvarova, Murray et al. 2004; Bedi, Yang et al. 2010; Bedi, Lago
et al. 2012; Keeler BE 2012). With these considerations in mind, it is important to
consider that the spatial parameters of experiments, with regard to both the level of SCI
and how the SCI affects the tissue investigated, can significantly influence the outcome.
Injury severity, or more specifically the location and degree of damage to the SC, is
another key factor that determines the functional capabilities of the spinal cord caudal to
a SCI. The literature is replete with examples of this when reports are considered
together, (Rossignol and Frigon 2011), however far fewer single studies examine
multiple injury severities (Magnuson, Lovett et al. 2005; Smith, Burke et al. 2006),
despite the fact that the degree of injury severity also significantly influences the
outcome.
Thus, we intially sought to characterize natural regulation of neurotrophin and trk
receptor genes in tissues and conditions that were most applicable to experimental studies
of long-term function and recovery after SCI and to conditions most often represented in
animal models and human studies. We characterized the transcriptional response of
neurotrophins and their cognate Trk receptors to spinal cord contusion temporally (6 and
12 weeks post-injury), spatially (in lumbar spinal cord and DRG), and relative to injury
severity (12.5 g-cm and 25g-cm NYU contusions).

3.2 Results
3.2.1. Injury Characterization
To assess the degree of injury severity, we characterized spinal cord injuries
based on two parameters; behavior as measured by BBB, and the amount of spared white
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matter at the epicenter after staining with eriochrome cyanin (Rabchevsky AG 2007).
BBB scores were significantly greater in the 12.5 g-cm injury groups than the 25 g-cm
groups beginning at week 5 (Fig 6a). These differences in behavior were reflected in the
amount of spared white matter, as the 25 g-cm groups had 8.5% (± 1.8%) and the 12.5 gcm groups had 13.9% ( ±3.6%) spared white matter at the epicenter. In accord with prior
literature (Basso DM 1996; Schucht P 2002; Magnuson DS 2005), a significant
correlation (r=0.88, p<0.001) was observed between white matter sparing at epicenter
and BBB scores (Fig 6b). BBB scores of the 12.5 g-cm group showed a high degree of
variability and continued to increase between 6 and 12 weeks instead of reaching a
plateau. Within this group, 2 animals had BBB scores consistent with the range observed
in previous literature (Basso DM 1996; Agrawal G 2010) (12 and 13) and 4 animals that
had higher BBB scores than expected for this injury severity (mean 17.9) at 12 weeks
post injury. We considered that these results may be due to both greater amount of spared
white matter (SWM) and/or asymmetry of the lesion (Fig 6c, 6d). Indeed, of the 4
animals whose BBB scores continued to increase, all had a greater amount of spared
white matter (mean 16.1% for 4 animals with higher BBB scores, 10.1% for 2 animals
with lower BBB scores), and all had asymmetrical injuries (arbitrarily defined as more
than 4% greater SWM on one side versus the other). Animals with the lower BBB scores
in the 12.5 g-cm group did not represent statistical outliers (Grubbs outlier test). Separate
statistical analyses of gene expression were performed with the exclusion of the 2
animals whose BBB scores did not continue to increase and the results generally did not
differ from those found when all 6 animals were considered together. The lone exception
was the results for expression of one Trk receptor in the spinal cord, which is noted
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below. We thus consider all 6 animals together in the group in all subsequent figures and
analyses of mRNA expression.

3.2.2. Expression of Trk receptors in the DRG
One purpose of this study was to determine whether these different contusion
severities result in a differential transcriptional response of neurotrophins and their Trk
receptors in lumbar sensorimotor circuits. Hence, we sought to determine the expression
level of Trk receptors in the DRG 6 and 12 weeks after our two severities of contusion
injury. Expression of TrkA, TrkB, and TrkC each differed significantly between the 6 and
12 week groups, with the magnitude and direction of difference depending on receptor
type and injury severity. Expression of TrkA mRNA in DRG from the 12 week group at
both injury severities was significantly greater than that in DRG from the corresponding
6 week group. Expression of TrkA in DRG from the 12 week group that received 12.5gcm injury was also elevated relative to the control groups. We also observed a difference
in TrkA expression between injury severities at the 12 week time point. Similar to TrkA,
expression of TrkC mRNA in DRG from the 12 week group was greater than that in
DRG from the corresponding 6 week group at both injury severities, but the difference
only reached significance in the 12.5 g-cm animals. Unlike the findings for TrkA, we
detected no significant difference in TrkC expression between DRG from the 12.5 g-cm
group and from the 25 g-cm group at the 12 week time point. Expression of mRNA for
TrkB in DRG at 12 weeks after 25 g-cm injury was significantly lower than in DRG from
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both the 6 week SCI and control groups. No significant difference in TrkB expression
was observed between injury severities at 6 or 12 week time points in the 12.5 g-cm
injury group (Fig. 7).

3.2.3. Expression of Neurotrophins in the DRG
As with TrkA, NGF mRNA expression in DRG from the 12.5g-cm injury severity
group was significantly greater in the 12-week group than in both the 6 week and control
groups. However, no significant changes in NGF expression were observed between
survival-time groups in the 25 g-cm injury severity group. As with TrkB, BDNF
expression in the 12 week 25 g-cm group was significantly less than in the 6 week 25 gcm group, but did not differ from the control group (Fig. 8). No other differences were
observed in BDNF expression levels. There was a large increase in the mean expression
of NT3 in DRG from the 12 week, 12.5 g-cm injury group, however due to high variance
no significant differences were observed from 6 to 12 weeks.

3.2.4. Expression of Trk receptors in the spinal cord
Expression levels of mRNA for neurotrophin receptors TrkA, TrkB, and TrkC
were assessed from samples of lumbar spinal cord (L4/5). In the groups that received a
12.5 g-cm injury, the level of TrkA in spinal cord from the 12 week group was
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significantly greater than that from the 6 week group, whereas there was no significant
difference between the two post-SCI times in the 25g-cm injury group. Like TrkA, the
level of TrkC in spinal cord from the 12 week 12.5g-cm group was significantly greater
than that from the 6 week group, with no significant difference between the two post-SCI
times in the 25g-cm injury group. No significant changes in TrkB expression levels were
detected between any groups (Fig. 9).

3.2.5. Expression of neurotrophins in the spinal cord
The results for neurotrophins in the spinal cord are displayed differently from the
data regarding expression levels of neurotrophins and Trk receptors in the DRG, and Trk
receptors in the spinal cord. In the aforementioned assessments, the expression of
neurotrophins and trks did not differ between the 6 week and 12 week control animals.
Thus, those data were analyzed and presented relative to the mean and variation of a
single unified control group. This allowed us to simultaneously assess the effect of both
injury severity and survival time on gene expression. For the neurotrophin genes in spinal
cord, however, expression differed significantly between the 6 week and 12 week control
groups (Figure 5A). We first analyzed these expression data exactly as was done for the
other tissues – comparing each injury severity and survival time to the mean and variation
of a single unified control group – but for the sake of clarity we have presented the data
from the individual animals in each group. Caution must be taken when considering the
expression data for the experimental groups in this analysis (Figure 10A) because of the
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use of a unified control group – i.e., these data were generated exactly as were the other
expression values, but are relative to a unified control group that, in this case, is not a
suitable control group. We found decreases between our 6 and 12 week control groups in
expression levels of NGF, BDNF, and NT3 in the spinal cord in the absence of spinal
cord injury. It is worth noting that our quality control measures were repeated for these
samples, but the assessments remained the same. In ruling out technical issues and
variability due to the necessity of using animals from different litters, a single factor
appears to account for the altered expression levels in the control groups, that being age.
Because the gene expression differed between the 6 week and 12 week control
groups, we cannot incorporate the temporal characteristic of the experimental design in
our assessment of neurotrophin expression in spinal cord. We are limited to analyzing the
effect of injury severity on gene expression within each separate survival time group,
where the data from experimental groups is expressed relative to the time-matched
control group only (Figure 10B). Considered in this way, spinal cord injury itself did not
significantly influence expression of any neurotrophin at any time considered, with the
exception of NT3 at 12 weeks post-SCI. At this time, NT3 was elevated relative to the
time-matched control group, with no effect of injury severity.

3.2.6. Relationship of transcriptional assessments to functional and anatomical
assessments
Our experimental design was intended to embrace the variability that exists with
models of contusive SCI in that we also examined whether a statistical correlation existed
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between expression levels of each transcript and BBB or white matter sparing on an
animal by animal basis. We observed no statistically significant correlation between the
expression levels of the transcripts and BBB score or white matter sparing.

3.3 Discussion
Spinal cord injury leads to many changes that affect both the central and
peripheral nervous system, indeed the entire organism, with residual functional capacity
largely dependent on the location and severity of the injury. Many approaches have been
used in efforts to re-establish function, including (but not limited to) enhancement of
regeneration across the injury site (Bregman BS 2002; Moon L 2005; Sharma H 2012;
Smith GM 2012) and plasticity of intact circuits below the level of the lesion (Edgerton
VR 2004; Boulenguez P 2009; Rossignol S 2011). One means for achieving plasticity of
intact circuits is through activity-dependent reorganization of inputs (Edgerton VR
2004)). This phenomenon has been described in both animal (Edgerton VR 2008) and
human (Harkema SJ 2008) studies of spinal cord injury. Neurotrophins have been
associated as playing a key role in induction of such changes (Hutchinson KJ 2004;
Boyce VS 2007; Côté MP 2011; Boyce VS 2012). However, activity-dependent changes
in locomotion often manifest at times later than those examined in studies of post-SCI
expression of neurotrophins and trk receptors (De Leon RD 1998; De Leon RD 1999);
(Table 3). Indeed, the dynamic period of spontaneous locomotor recovery generally lasts
for approximately 6 weeks after SCI, a time well beyond the majority of previous studies
(Table 3). In addition to a putative role in locomotor function, neurotrophin signaling has
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also been implicated in pathologic outcomes of plasticity such as post-SCI pain and
autonomic dysreflexia (Brown and Weaver 2012). The role of neurotrophin signaling has
primarily been examined in terms of initiation of these conditions acutely after SCI in
animal models (Krenz, Meakin et al. 1999; Marsh, Wong et al. 2002; Cameron, Smith et
al. 2006), as opposed to later-phase initiation or maintenance. The regulation we have
demonstrated at extended time points may provide new rationale for examining the role
of neurotrophin signaling in later stages of these conditions.
Neurotrophins exert modulatory effects on cellular physiology through activation
of their cognate Trk receptors (Lindsay RM 1996; Patapoutian A 2001; Huang EJ 2003).
In the DRG, expression of neurotrophin receptors is restricted to specific populations of
cells. Generally, TrkA is expressed in neurons with small soma size, TrkB in neurons
with intermediate size, and TrkC in neurons with large soma size; populations of TrkA
and TrkC expressing neurons remain largely separate, whereas TrkB is co-expressed in
overlapping populations of TrkA and TrkC positive cells (Mu X 1993; McMahon SB
1994; Wright DE 1995; McMahon SB 1996; Phillips HS 1996). Trk receptors are not
ubiquitous, however, as there is a large subpopulation of small diameter DRG neurons
which do not express any of the Trk receptors or the low-affinity neurotrophin receptor
p75 in the adult (McMahon SB 1994; Molliver DC 1997; Bennett DL 1998). In the
mammalian spinal cord, TrkA is expressed in second order nociceptors of the dorsal
horn, TrkB has a broad pattern of expression which overlaps with both TrkA and TrkC
expression, and TrkC is expressed in neurons of the intermediate and ventral horn
(Duberley RM 1997; Curtis R 1998; Schober A 1999; Copray S 2000; Liebl DJ 2001);
also available from: http://mousespinal.brain-map.org.
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As long as 6 weeks after spinal cord transection injury, the number of cells
expressing TrkA and TrkB protein in L1 and L6/S1 DRG (containing bladder afferents)
increases over controls, though the numbers of cells expressing these genes does not
significantly change in L4/5 DRG (Qiao L 2002; Qiao LY 2005). Our analysis of Trk
expression, which was also performed in L4/5 DRG, found no significant change in the
trkA or trkB mRNA levels for either severity of contusion injury at 6 weeks post injury,
in agreement with the prior work. In intact sensory and sympathetic ganglia of the adult
rat, NGF and NT3 (as well as TrkA, full length TrkB, and TrkC), localize exclusively to
neurons; BDNF and the truncated isoform of TrkB are expressed more extensively,
however, localizing to neuronal cells and some glial and satellite cells (Wetmore C
1995). These observations are consistent with the notion that full length Trk expression
predominantly occurs in neurons, though since the latter study was performed with intact
animals, we cannot exclude the possibility that our injuries potentially resulted in ectopic
expression in other cell types. Indeed, there are numerous reports of trk receptor
expression by non-neuronal cells. In particular Schwann cells can express trks, as can
cancer cells (Funakoshi, Frisen et al. 1993; Tacconelli, Farina et al. 2005; Hess, Scott et
al. 2007; Jin, Lee et al. 2011). Further, neurotrophins are often expressed in non-neuronal
cells, most notably by cells outside the nervous system where they influence both
developmental and adult processes (Lewin 1996; Petruska and Mendell 2004).
Previous assessments of changes in neurotrophin/Trk receptor expression levels
after spinal cord injury have typically focused at time points of less than 6 weeks. BDNF
expression increases up to two weeks after injury in the spinal cord after thoracic
transection and crush injury (Hayashi M 2000; Li XL 2007), though both increases and
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decreases in expression have been reported after hemisection during a similar time period
post injury (Gulino R 2004; Qian DX 2006). Expression levels of NGF and NT3 in the
cord increase for up to 3 weeks after spinal cord injury (Hayashi M 2000; Li XL 2007).
In another study, NGF and BDNF transcripts were found to increase up to 4 days
following injury in the adult cord, however, by 2 weeks post injury all neurotrophins
were expressed at levels similar to that of control (Nakamura M 2001; Widenfalk J
2001), suggesting expression decreases after an early increase, though these studies used
different injury models. Trk mRNA expression is downregulated acutely in the spinal
cord at and around the injury site after contusion (Liebl DJ 2001; Hajebrahimi Z 2008),
however by 6 weeks expression levels are not different from control (Liebl DJ 2001).
However, after spinal cord transection TrkC has been shown to increase after two weeks
(Qian DX 2011). Similarly, in a recent study assessing mRNA and protein changes after
transection at 10 and 31 days post injury, whole spinal cord TrkB mRNA was elevated at
10 days post injury, and whole spinal cord NT3 and TrkB protein was elevated at 31 days
post injury, with expression differences also observed depending on the location within
the parenchyma of the spinal cord (Keeler BE 2012). Table 1 summarizes the findings of
recent experiments to facilitate comparison of these results.
We found TrkA expression increases in both the DRG and spinal cord of animals
after contusion in a manner that was dependent on injury severity. This finding is of
particular interest with regards to the functions of NGF and TrkA. NGF plays a welldefined role in sensitization of nociceptive afferent neurons (Shu X 1999; Shu X 2001;
Galoyan SM 2003; Zhu W 2004). Nociceptive DRG neurons undergo changes after SCI,
including development of spontaneous activity (Bedi SS 2010) and an enhanced intrinsic
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growth promoting state (Bedi SS 2012). Such changes in anatomical and physiological
properties of nociceptors may contribute to development of conditions such as autonomic
dysreflexia (Marsh DR 2002)). TrkA antagonists prevent the sensitization (thermal and
mechanical hyperalgesia) normally induced by partial nerve injury (Ma WY 2010), and
antagonism of TrkA signaling has been effective for controlling human pain (Mantyh PW
2011). Hence, elevation in the levels of TrkA and NGF in response to contusive injury
could play a role in some of the maladaptive processes after incomplete SCI.
TrkB activation has also been implicated in hypersensitivity to nociceptive input
and sensitization of nociceptors (Kerr BJ 1999; Shu XQ 1999; Garraway SM 2003).
However, after either SC transection or contusion injury, BDNF induced facilitation of
afferent responses in lamina II of the dorsal horn is significantly reduced (Garraway SM
2005; Garraway SM 2007). Our results could suggest a mechanism for those
physiological observations. In addition to TrkB expression in populations of second
order nociceptive neurons (Schober A 1999), it is expressed robustly throughout the
interneuronal circuitry, and also co-expressed along with NT3 in motoneurons (Buck CR
2000), a finding corroborated in humans (Josephson A 2001). Notably, BDNF
administration to the injured spinal cord can improve locomotor outcomes, however
because of its influence on nociceptive circuitry its therapeutic utility may be limited
(Boyce VS 2012).
In DRG, TrkC is present on medium to large diameter muscle spindle afferents
that make monosynaptic connections with motoneurons and cutaneous low threshold
mechanoreceptors (Klein R 1994; Oakley RA 1997; Josephson A 2001) in the
intermediate and ventral horns of the spinal cord. NT3, likely acting via TrkC, can exert
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a modulatory effect on sensorimotor circuits in both intact (Petruska JC 2010) and injured
preparations (Mendell LM 2001; Arvanian VL 2003; Arvanian VL 2006; Arvanian VL
2006; García-Alías G 2011; Schnell L 2011). Locomotor training after spinal cord injury
is associated with increased expression levels of TrkB and TrkC agonists in rats
(Hutchinson KJ 2004; Côté MP 2011). In addition, co-administration of both BDNF and
NT3 to the injury site has been shown to improve hindlimb locomotion after transection
in both rats (Blits B 2003) and cats (Boyce VS 2007). Taken together, these findings
suggest a potential role for Trk activation in modulation of lumbar sensorimotor circuitry
in both intact and injured animals.
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CHAPTER 4
NEUROTROPHINS AND AGING IN THE SPINAL CORD
4.1 Introduction
The apparent age-related regulation of NGF, BDNF, and NT3 in non-injured
spinal cord was unexpected and we made significant efforts to identify possible technical
and sampling issues. While those factors that often account for variability did not
satisfactorily account for the expression patterns we observed, the single factor of age did
appear to fully account for the differences. Expression of the neurotrophins has been
examined in the context of embryonic and postnatal development and in aging (e.g.,
(Timmusk, Belluardo et al. 1994; Nosrat 1998; Bergman, Ulfhake et al. 2000). However,
to the best of our knowledge, there has been no systematic assessment of the regulation of
the neurotrophins at such late postnatal times, leading us to postulate that perhaps there
was a previously undocumented age related decrease in neurotrophin expression that
persisted throughout the lifespan of the adult rat.
Much of the literature concerning neurotrophins and aging comes from
assessments of expression levels in the forebrain. In the cortex and hippocampus, the
mature form of NGF levels decrease relative to age in naïve animals, while BDNF levels
remain unchanged (Perovic, Tesic et al. 2012). However, other studies that sampled
multiple areas throughout the forebrain and also the sciatic nerve found no significant
difference in levels of NGF, BDNF, or NT3. These changes appear to be region specific
however, as increases in the levels of BDNF in the hippocampus, as well as increases in
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levels of NT3 in the cerebral cortex have been documented(Katoh-Semba, Semba et al.
1998). Thus, we sought to determine whether the changes we observed from 6 to 12
weeks in the spinal cord were due to regional specificity within the spinal cord and
whether these changes persisted throughout the lifespan of the adult rat

4.2 Results
4.2.1 Expression of NGF, BDNF, and NT3 at 3, 6, 9, 12, and 15 months after birth in
the uninjured rat spinal cord
Unlike the decreases that we observed for all neurotrophins from 3 to 6 months in
the adult rat, these changes did not persist throughout the course of adulthood based on
further analysis at 9, 12, and 15 months after birth (NGF Fig 11, BDNF Fig 12, NT3 Fig
13). The only significant change in the levels for any of the neurotrophins was an
increase in the levels of NT3 at 9 months after birth, above the levels of 3 and 6 month
uninjured rats (Fig 13).

4.3 Discussion
Though the observation that the trend of decreasing expression did not persist
through the lifespan of the adult rat was somewhat surprising, there are several factors
that provide rationale for the explain differences we observed. The animals we used at
our 9 and 15 month time points had been used for the purpose of breeding and were
housed at a different location. This could have resulted in several differences between
these animals and the animals used for the 3, 6, and 12 month after birth groups. One was
simply that the 9 and 15 month groups had been pregnant. During pregnancy, uterine
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receptivity to implantation is dependent on levels of progesterone (Bazer, Burghardt et al.
2008). Progesterone plays a role in neuroprotection via regulation of BDNF (Su,
Cunningham et al. 2012; Singh and Su 2013). Progesterone has also been shown to
maintain levels of NGF (Tometten, Blois et al. 2005), thus a putative link between
neurotrophins and hormones regulated during pregnancy is plausible. Another difference
between the groups of rats were the environments in which they were placed.
Additionally, environmental enrichment in the adult rodent nervous system has been
shown to protect the brain from age-related dysfunction, which can be accomplished
through induction of NGF (Mohammed, Henriksson et al. 1993) and BDNF (Cirulli,
Berry et al. 2010) expression, and could also play a role in regulation of neurotrophin
levels. Though these mechanisms might certainly be involved, the observation that no 12
and 15 month after birth groups differed in their expression levels (12 month animals
were conditioned in a similar environment to the 3 and 6 month groups, and did not give
birth) raises questions as to the validity of this argument.
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CHAPTER 5
COORDINATED EXPRESSION OF NEUROTROPHINS AND TRK
RECEPTORS IN DRG AT 12 WEEKS POST INJURY
5.1 Introduction
12 weeks after injury there were analogous increases in the NGF and NT3 from
the expression levels we observed at our 6 weeks time points. Since all assessments were
obtained from samples that were derived from the same animals, we sought to determine
whether these increases extended concomitantly within each sample. Thus, we next
calculated the correlation coefficient between all neurotrophins(i.e. NGFvNT3,
NGFvBDNF, BDNFvNT3), their Trk receptors(i.e. TrkAvTrkC, TrkAvTrkB,
TrkBvTrkC), and between each neurotrophin ligand and its cognate receptor(NGFvTrkA,
BDNFvTrkB, NT3vTrkC). Such interactions that regulate expression levels of different
neurotrophins have been reported in different cellular and animal models previously
(Leingärtner A 1994; Canossa, Griesbeck et al. 1997; Gratto and Verge 2003; Mallei,
Rabin et al. 2004; Kuo, Groves et al. 2007), however none have investigated whether
such patterns emerge between all neurotrophins and Trk receptors at more chronic time
points after contusive SCI.
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5.2 Results
To further characterize the relationship between the neurotrophins and their receptors in
lumbar DRG and spinal cord, we analyzed the expression levels of neurotrophins and Trk
receptors relative to each other, and without respect for injury severity. In the spinal cord,
the only significant relationship was that of TrkB and TrkC in the control and 6 week
groups. No relationship was found between any other expression levels at any time
points in the spinal cord (Table 2). In the DRG, there was a relationship between NGF
and NT3 in all groups. In the 6 week groups the only other significant correlation
observed was between BDNF and TrkB. After 12 weeks there was a significant
correlation in the expression levels of all neurotrophins in the DRG, a relationship that
existed for the Trk receptors as well (Table 3). Additionally, a significant correlation was
observed between expression levels of neurotrophins and their cognate Trk receptors at
12 week time points (Table 3). This coordinated expression pattern occurred in all
animals independent of injury severity (Figures 14 & 15). The reliability of this statistical
assessment is enhanced by our performing the reverse-transcription for all samples with
the same reagents, a procedure which reduces the cross-sample variability.

5.3 Discussion
12 weeks post injury a coordinated expression pattern emerged when comparing
all neurotrophins and Trk receptors to one another. This pattern was independent of
injury severity, and was also present between the neurotrophins and their cognate Trk
receptors in the DRG (Tables 1and 2, fig’s. 5 and 6), a relationship that was not evident at
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6 weeks post-SCI, nor for expression levels in the SC. Although there are reports of
smaller groups of neurotrophins and/or Trks being regulated in a coordinated fashion
(Widenfalk, Olson et al. 1999), to our knowledge this degree of coordination has not been
reported. One obvious possibility is a feedback/feedforward relationship between
some/all of these genes, and these sorts of relationship do exist (Michael, Averill et al.
1997; Wyatt, Middleton et al. 1999; Gibbons and Bailey 2005).
Neurotrophin dependent neurotrophin expression has been demonstrated in vitro
in NIH3T3 and PC12 cells (Canossa M 1997; Mallei A 2004), hippocampal neurons
(Canossa M 1997), and cerebellar granule neurons (Leingärtner A 1994). In vivo,
intrathecal administration of NT3 to intact adult animals for one week results in reduced
expression of TrkA protein in the DRG, but has no effect on levels of TrkC (Gratto KA
2003). After unilateral axotomy, sub-cutaneous administration of exogenous NT3
similarly causes a decrease in TrkA on the side contralateral to the injury. This contrasts
to the increase in TrkA expression seen on the side ipsilateral to the injury; the effect of
NT3 on expression levels of TrkB and TrkC however is not affected by injury in this
paradigm, as levels of these transcripts show increased expression up to 4 weeks post
axotomy in both ipsi- and contralateral DRG (Kuo LT 2007). Such coordinated
expression patterns could result from changes at the epigenetic level or from potentially
from interactions between the different transcription factors associated with expression of
specific transcripts.
In (Hougland et al. 2012), bioinformatic analyses were performed in an attempt to
elucidate potential underlying factors involving miRNA and common transcription
factors that may underlie the expression patterns that were observed between

37

neurotrophins/Trks. Though no common miRNA targets were revealed through a
TargetScan analysis of 3’-UTRs, this was likely due to the search criteria inherent in the
bioinformatic platform that was used. TargetScan only retrieves targets that have been
experimentally confirmed, thus the absence of a finding likely reflects a lack of preceding
investigations into the subject rather than simply a negative finding. Likewise, in
searching for common transcription factors that regulate expression of these genes, no TF
was retrieved that involved regulation of TrkC. This was due to stringent filtering
processes that relegated all returned queries to those validated as being expressed in the
nervous system (Hougland, Harrison et al. 2012). Despite the exclusion of TrkC as a
result of this filtering process, TrkC has several well established transcription factors that
play a role in determining its expression in the nervous system, notably; Runx3
(Levanon, Bettoun et al. 2002), Runx1, Brn3a, (Zou, Li et al. 2012)and REST (Nakatani,
Ueno et al. 2005).
During development, Runx1 and Runx3 transcription factors play essential roles
in cell fate determination of nociceptive (Chen CL 2006) and proprioceptive (Inoue K
2002) neurons, respectively. Much attention regarding transcriptional regulation of
neurotrophin expression in the mature nervous system has been given to BDNF, due to its
role in activity dependent mechanisms during long-term potentiation (LTP). Such
investigations have revealed several important transcriptional regulators including; cyclic
AMP response element binding protein (CREB), calcium-responsive transcription factor
(CaRF), and methyl CpG-binding protein 2 (MeCP2) (Tao X 1998; Tao X 2002; Chen
WG 2003; Reichardt LF 2006). Such findings may facilitate future efforts to determine
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the mechanisms regulating the expression of the neurotrophins and Trk receptors in the
injured adult spinal cord and sensory ganglia.
Despite the absence of TrkC from the analysis, (Hougland et al 2012) identified 4
TFs that potentially interacted with the entire set of remaining genes. The majority of
literature regarding these TFs and their involvement in regulation of neurotrophins and
Trks is in the context of development or cancer. Accordingly, the authors could not
identify any studies examining Pax3, NeuroD, or MafB in spinal cord or DRG in the
context of SCI. Maf has been studied in relation to neurodegeneration (Kobayashi,
Tsukide et al. 2011) and in stress (Machiya, Shibata et al. 2007). Pax3 was studied in
relation to nerve injury, where it was found to not be regulated (though this does not
imply it not being active) (Vogelaar, Hoekman et al. 2004).
There are studies examining CREB in spinal cord (Canossa, Griesbeck et al.
1997; Copray and Kernell 2000; Crown, Ye et al. 2006; Cote, Azzam et al. 2011) or DRG
(Qiao and Vizzard 2005) in the context of SCI, with the latter study examining the TrkA,
TrkB, and CREB, though not in direct relation to each other. Interestingly, the expression
of activated CREB in the DRG changed over the course of the first 6 weeks after SCI,
with the levels at 6 weeks being significantly greater than controls, though not in the
DRG we examined here. After a conditioning lesion to the peripheral nerve, enhanced
regeneration of the central branches can be observed and is dependent on elevation of
cAMP within the DRG. (Neumann, Bradke et al. 2002; Yang and Yang 2012)Other
studies demonstrate induction of CREB in injured/stressed neurons and also in neurons
post-synaptic to stressed sensory neurons (Ji and Rupp 1997; Bedogni, Pani et al. 2003;
Choi, Kim et al. 2003; He, Csiszar et al. 2003; Zhu, Lau et al. 2004), while others
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demonstrate CREB regulating multiple NTs (Bender, Lauterborn et al. 2001), in at least
one case by interacting with cytokines (Otten, Marz et al. 2000).
Our data was derived from homogenized tissue, thus we cannot make conclusions
about apparent coordinated expression on the basis of individual cells, though we can
draw from a number of sources to make inferences about what may potentially be
happening.

1) There is some evidence that at 6 weeks after SCI trk receptors are expressed
almost exclusively in DRG neurons, similar to before the SCI (Qiao and
Vizzard 2002; Qiao and Vizzard 2005). However, it must be noted that there
is a wealth of evidence that suggest expression of NTs and Trks in nonneuronal cells (e.g., (Funakoshi, Frisen et al. 1993; Elkabes, Peng et al. 1998;
Nemoto, Fukamachi et al. 1998; Noga, Englmann et al. 2002; Hess, Scott et
al. 2007), although much of this is in the context of cancer (e.g., (Tacconelli,
Farina et al. 2005; Howe, Cochrane et al. 2011; Jin, Lee et al. 2011). Studies
which identify the cell types expressing the NTs or Trks are necessary as it is
possible that at least a portion of the tissue-level regulation could be due to
invading cells. Certainly the complement of immune cells in the spinal cord
is affected by injury, even in segments spatially remote from the injury (e.g.,
(Popovich, Wei et al. 1997). Immune cells invade the DRG after nerve injury
(e.g., (Nguyen, O'Barr et al. 2007; Vega-Avelaira, Geranton et al. 2009; Kim
and Moalem-Taylor 2011), but this possibility has not been examined in
DRG at any time after SCI. However, evidence suggests that the immune
cells and their functions throughout the body may be affected by SCI (e.g.,
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(Popovich, Stuckman et al. 2001), and some express Trk receptors and/or
neurotrophins (e.g., (Noga, Englmann et al. 2002; Nassenstein, Kerzel et al.
2004; Tabakman, Lecht et al. 2004).

2) There are certainly studies which examine the chronic post-SCI condition,
but we could not identify any that could provide data relevant to these
specific considerations (i.e., they examined other readouts).

Almost irrespective of the outcome of the above considerations, there is still
another consideration that can be brought to bear. Although there are papers describing
co-expression of some of these genes in single cells where common genetic/molecular
regulation could possibly be at play, it is highly unlikely that all the coordinated
expression is accounted for by single cells. Even in the condition where expression is
limited to neurons, and even to the same population of neurons that expressed these genes
in the intact system (i.e., differences in expression would be based on volume regulation
in any given cell and not on recruitment/de-recruitment of cell populations), what is the
likelihood that this degree and scope of coordinated expression could occur across
different cell types independently? It seems unlikely that each of the genes considered
would change in a single cell type independent of its regulation in any other cell type, and
still display such relatively similar expression levels. However, because there is little-tono cellular expression data here or in the literature from which to extrapolate the identity
of the cells expressing these genes (i.e., immunocytochemical or in situ hybridization
assessment of DRG 12 weeks post-SCI), we must acknowledge that this is possible.
There is, however, virtually no reason to expect that individual cells would express all of
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the “coordinated” genes and thus have the mechanism of coordinated regulation exist
fully inside of those given single cells. Therefore, at least some of the coordination must
arise across cells which express one or more of the “coordinated” genes, thought whether
this is due to the protein products of the genes themselves or an outside factor is unclear.
Additionally, there might also be a shared biological process(es) or response(es)
being executed in various different cells – a process that has similar outcomes in terms of
gene regulation but arrives there through actions of different specific molecular entities.
For “simplicity”, let us consider that only the neurons of the DRG are involved. Even this
cell population is not homogeneous in function, form, or sensitivity. Each of the Trk
receptors is expressed largely in separate subpopulations. Given the dissimilarities of
their regulatory sequences, they may each be directly regulated by distinct factors.
However, conditions may arise that induce the non-homogeneous neuronal types,
regardless of the specific trk they express (and thus which specific factors will act on the
DNA and/or mRNA), to coordinately regulate the expression of their trk receptor. It is
possible that the regulation of those specific factors may be under a control mechanism
that is itself shared across the different neuron types. Our analysis would not detect this.
As an example, consider cellular stress or injury. Numerous authors have reported on the
regulation of Trks and neurotrophins in response to nerve injury, and the change in
expression over time (Ernfors, Rosario et al. 1993; Sebert and Shooter 1993; Krekoski,
Parhad et al. 1996; Yamamoto, Sobue et al. 1996; Bergman, Fundin et al. 1999; Lee,
Zhuo et al. 2001; Kuo, Groves et al. 2007), and many aspects of our data agree with
reported regulation after nerve injury or neuronal stress. Intriguingly, there was another
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report of “coordinated regulation” associated with DRG neurons and glia in conditions of
injury and/or stress (Cameron, Vansant et al. 2003).
Presently it is unclear whether SCI induces any long-term injury or stress on DRG

neurons. Certainly the central axons of some DRG neurons are damaged in SCI,
particularly those terminating in the affected cord, or with long axons ascending through
the dorsal columns (Huang, Robson et al. 2006). However, effects of injury to central
axons differs from those of injury to peripheral axons (Stam, MacGillavry et al. 2007),
and the long-term effects on expression of neurotrophins and trk receptors has not been
examined. Injury to central axons is not the only possible source of stress to sensory
neurons, however. The inflammatory condition of the spinal cord and continued spread of
damage may induce injury or stress in sensory neurons at times remote from the acute
SCI, and at locations remote from the lesion (Popovich, Wei et al. 1997; Popovich 2000;
Bao, Chen et al. 2004; Fleming, Norenberg et al. 2006; Gris, Hamilton et al. 2008; Kwon,
Stammers et al. 2010; Bao, Brown et al. 2011; Lubieniecka, Streijger et al. 2011; Ng,
Stammers et al. 2011; Stammers, Liu et al. 2012). There is a systemic inflammatory
condition (Fleming, Norenberg et al. 2006; Gris, Hamilton et al. 2008; Bao, Omana et al.
2012) that has unknown effects on these neurons. Additionally, one must consider the
effects of SCI on peripheral tissues innervated by sensory and motor neurons. The
inflammation and altered activity/mobility/use state can impact these tissues (EdwardsBeckett and King 1996; Lynch, Anthony et al. 2000; Gris, Hamilton et al. 2008) with
uncertain consequences for the innervating neurons. The increased expression of galanin,
a neuropeptide induced in DRG neurons by stress/injury (Suarez, Guntinas-Lichius et al.
2006), in the DRG innervating bladder and bowel (but not other DRG) after SCI
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(Zvarova, Murray et al. 2004) suggests that the histopathology secondary to SCI may
stress the sensory neurons innervating those tissues. Tissue damage has been shown to
induce stress/injury responses in sensory neurons (Ivanavicius, Ball et al. 2007; Hill,
Harrison et al. 2010; Thakur, Rahman et al. 2012), and has been shown to affect
regulation of multiple neurotrophins in the injured tissue (Vizzard 2000).
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CHAPTER 6
EXPRESSION OF INFLAMMATORY MARKERS AFTER SCI
6.1 Introduction
Cytokines such as IL-6 have been shown to induce expression of NGF, NT4/5,
and NT3 from cultured astrocytes (Otten, Marz et al. 2000). In rodents after injury, IL-6,
IL-1α, IL-1β, IL-13, CCL2, MIP1α, RANTES, and TNFα are elevated acutely in the
spinal cord(Stammers, Liu et al. 2012). In humans, protein levels measured from CSF of
injured patients indicate that assessment of some of the same molecules can serve as a
biomarker for injury severity, including IL-6, IL-8, CCL2, tau, S100beta, and glial
fibrillary acidic protein(Kwon, Stammers et al. 2010). Based on the data presented in the
previous chapters, we deduced several scenarios that could be at play. It is possible that
neurotrophins alone could be regulating their own expression and that of Trk receptors.
We also considered, based on the data mentioned above, that a common factor or
mechanism might be influencing expression, such as infiltration of immune cells
expressing inflammatory cytokines, or simply cytokines endogenously expressed by cell
types resident within the nervous system.
To investigate whether a cytokine/receptor or other inflammatory molecule is
responsible for the expression patterns observed among the set of neurotrophins/Trks, we
limited our targets to a specific (and partially overlapping) subset of factors that we felt
represented a broad range of molecules involved in these processes. These included: IL6,
LIF, and CNTF, a related set of ligands that bind the common GP130 co-receptor(a
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molecule which was also included), the cytokine TNFa, iNOS, a protein that is induced to
form Nitric Oxide as an immune defense mechanism, CD11b, an integrin present on the
surface of leukocytes that mediates immune cell adhesion, Interferon gamma and the
chemokine CCL2(aka MCP1).

6.2 Results
6.2.1

Gene targets without appreciable expression levels
Several of the genes we chose to investigate were not expressed to detectable

levels in the DRG. All reactions were run in duplicate, and the criteria for detectable
gene expression was when more than one of the samples(1 set of duplicates) within more
than one of the 6 groups(6wk control, both 6wk injury groups, 12wk control, and both
12wk injury groups) failed to reach the Ct threshold for the gene of interest. The genes
included in this list are: IL6, IL10, iNOS, and Interferon gamma (data not shown).

6.2.2

Gene targets whose controls were unchanged from 6 to 12 weeks
Genes that were expressed at appreciable levels were divided into two groups

depending on whether or not expression of their control groups changed significantly
from 6 to 12 weeks post surgery. There were four genes that had no change in the control
groups from 6 to 12 weeks; CD11b, LIF(Fig 16), TNFa in DRG and SC(Fig 17), and
gp130. Of these four genes, only gp130 showed any significant changes. For gp130, in
the 12.5gcm 12 weeks post injury, expression levels were elevated significantly above the
control group, as well as both of the 25 gcm injury groups. In animals that received a 25
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gcm injury, expression levels were reduced significantly from 6 to 12 weeks post
injury.(Fig 18)

6.2.3

Gene targets whose controls changed from 6 to 12 weeks
Genes that had changes in the expression of controls from 6 to 12 weeks were

CNTF and CCL2. For CNTF, all 12 week groups showed a significantly increase relative
to the 6 wk control and 6 wk 12.5 gcm groups. However, since controls increased from 6
to 12 weeks, it also helps to assess levels relative to time matched control. If this is done,
the 6 wk 25gcm group is significantly above the 6 wk control group, while all other
relative expression levels are not significant. (Figure 19) For CCL2, control expression
levels decreased from 6 to 12 weeks, but in contrast the injury groups were substantially
increased. (Fig 20)
Note: Figure 21 and 22 for discussion purposes

6.3 Discussion
Interleukins are cytokines that exhibit a diverse array of effects across different
cell types and tissues (Brocker, Thompson et al. 2010). Interleukins can exert both proand anti-inflammatory effects, and serve to activate and modulate differentiation of
immune cells in response to inflammation (Commins, Borish et al. 2010). IL6 belongs to
a family of cytokines that have a broad range of effects stemming from their various roles
in inflammation, immune response, and cell survival and differentiation (Jazayeri, Carroll
et al. 2010), and can be further characterized based on whether or not they are
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biologically active as monomers or heterodimers. Those of the monomeric subdivision
bind through the common co-receptor subunit gp130 (also known as IL6ST) (Boulay,
O'Shea et al. 2003; Heinrich, Behrmann et al. 2003), which also includes(among others)
LIF and CNTF. LIF signals through gp130 in combination with LIF receptor (LIFR)
(Plun-Favreau, Perret et al. 2003), while CNTR signals through a heterotrimeric complex
that includes both gp130 and LIFR as well as the CNTF receptor (CNTFR) (Stahl and
Yancopoulos 1994).
Expression of IL6 can be stimulated through signaling complexes of other
cytokines such as TNFa, IL1, and LIF, as well as in an autocrine fashion. This occurs
through binding of nuclear factor IL6 (NF-IL6) to an IL1-responsive element within the
IL6 promoter (Akira, Isshiki et al. 1992), and also activates transcription through
phosphorylation of STAT3 tyrosine kinase (Akira 1997). In contrast to IL6, IL10 is
biologically active as a homodimer and acts through the JAK/STAT pathway to suppress
expression of pro-inflammatory cytokines, and is thus an important anti-inflammatory
molecule (Murray 2007). These cytokines, along with the evolutionary related
Interleukins in both of their family, are expressed by white blood cells in response to
infection and injury (Dinarello and Mier 1986). In addition, CD11b is an integrin
expressed on the cell surface of white blood cells that mediates adhesion and migration of
leukocytes (Solovjov, Pluskota et al. 2005). They are important mediators of the immune
response and are highly expressed after insult to the body, thus due to the lack of
expression (or change in expression in the case of CD11b) we observed, it is unlikely that
the infiltration of white blood cells that express these molecules into the DRG can explain
the patterns of expression that were observed in our previous studies. Despite our data
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suggesting that the IL6 cytokines that are biologically active as monomers and TNFa do
not appear to be responsible for the expression pattern of neurotrophhins 12 weeks post
SCI, we did not investigate the IL6 cytokines biologically active as heterodimers, nor did
we investigate other Interleukins or cytokines. Since these molecules comprise expansive
families of molecules that mediate immune response in a wide variety of ways, our
analysis is by no means exahaustive.
IL6, LIF, and CNTF have differing effects on the survival of cultured newborn rat
DRG neurons. Specifically, both CNTF and LIF are able to promote survival of these
neurons (Simon, Thier et al. 1995), and enhances neurite outgrowth in both large
diameter and small diameter cells of the DRG, while IL6 does not (Sango, Yanagisawa et
al. 2008). This finding however, is likely due to the IL6 receptor not being sufficiently
expressed at this developmental stage, as supplying both the IL6 ligand and soluble
receptor does support survival (Thier, Marz et al. 1999). In vivo, CNTF is expressed by
Schwann cells, and after peripheral nerve injury is released to promote axonal
regeneration and neuron survival. However, when primary DRGs are explanted and
cultured, neurons begin to also express CNTF, which is localized to both the soma and
dendrites (Sango, Yanagisawa et al. 2007). This could be due either to disruption of cellcell contact, or potentially a response to injury by the explanted neurons. We observed
that CNTF levels were elevated above that of controls 6 weeks post injury in a
moderately severe (25 gcm) contusion. However, though the expression levels of both
the 12 week control and injury groups are elevated above controls in the 6 week post
injury groups, CNTF levels returned to that of controls by 12 weeks post injury relative
to the time matched control. Thus, the increase in CNTF seen at 6 weeks does not persist,
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and the further increase in CNTF expression above 6 week levels is likely only a function
of aging, a finding that is supported in previous literature (Nakamura and Bregman
2001).
Our investigations of inflammatory markers that potentially influence expression
of the neurotrophins and their Trk receptors targeted three groups of molecules that serve
separate, yet overlapping functions: cytokines, interferons, and chemokines. Cytokines
mediate growth, differentiation, and activation during an immune response. This
contrasts with chemokines, which serve to direct immune cells to sites of inflammation
via chemotaxis; and inteferons, which directs cellular responses to viral infections
(Commins, Borish et al. 2010). Interferon gamma was the only interferon that was
assessed, due to its important role in cell-mediated immunity (Farrar and Schreiber 1993),
and had undetectable levels of expression. The only chemokine (White, Sun et al. 2005)
assessed was Chemokine ligand 2(CCL2), also known as Monocyte Chemotactic
Protein(MCP1). Expression of CCL2 was essentially the same as control at our 6 week
time point, but at 12 weeks post injury had risen to approximately 8 times the level of the
control group in both injury severities. CCL2 leads to hyperexcitability of DRG neurons
both in culture and in vivo (White, Sun et al. 2005). Additionally, many models of
neuropathic pain induce potent expression of CCL2, (Tanaka, Minami et al. 2004; Jeon,
Lee et al. 2008; Bhangoo, Ripsch et al. 2009; Jeon, Lee et al. 2009; Foster, Jung et al.
2011) and knockout mice lacking its receptor CCR2 (Abbadie, Lindia et al. 2003), or
pharmacological blockade (Serrano, Pare et al. 2010) impairs the development of
neuropathic pain. This hyperalgesic response is due to upregulation of the current density
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and expression of TRPV1 (Kao, Li et al. 2012) and Nav1.8 (Belkouch, Dansereau et al.
2011).
In the rodent and human spinal cord, CCL2, along with several other
inflammatory cytokines, can be used as a correlative biomarker for injury severity
(Kwon, Stammers et al. 2010; Stammers, Liu et al. 2012). We observed that CCL2 was
upregulated in our 25 gcm group at 12 weeks post-injury. Though the discrepancy
between our findings and that of the previous studies is unclear, there are a number of
parameters that were different between the experiments. In the previous rodent studies,
the time points assessed only extended to 24 hours post injury. Though a contusion injury
was also used for the purposes of their studies, the injury was performed using the OSU
impactor rather than the NYU device. As shown earlier, not only can the type of
contusion effect the levels of expression but even the severity within the same type of
injury model. These previous also assessed protein levels, whereas only mRNA was
examined for the purposes of our study. In terms of the human study, protein levels were
also examined, though from the CSF and the blood serum, and the time period was up to
72 hours post injury. These vastly different time points and methods of injury very likely
contributed to the differences observed between the findings of these previous studies and
our own.
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CHAPTER 7
GENERAL DISCUSSION
Through our characterization of neurotrophins and their Trk receptors we found
that from 6 to 12 weeks post-contusion there were differences in the mRNA expression
levels of these molecules, and this difference was dependent on the severity of the
contusion. Based on previous data that use different models of spinal cord injury and
assess neurotrophin/Trk levels at various times (Table 1), the observation that there is an
injury severity dependent difference in expression of individual transcripts is not
surprising. This highlights the importance of characterizing any experiment in terms of
injury model, time point, and injury severity. However, it nevertheless elicits the question
of why the difference exists? One explanation is that there are different levels of activity
below the level of the injury. It is feasible to think that differing levels of descending
input(based on which fibers are spared) lead to concomitant changes to the motoneurons
basal levels of excitability, perhaps through remaining monoaminergic synapses
(Heckman, Lee et al. 2003; Anelli, Sanelli et al. 2007; Murray, Stephens et al. 2011).
This could in turn result in tonic levels of muscle activity and subsequent levels of
afferent activity that are affected relative to the amount of spared descending input.
Another possibility is that the nervous system is reacting to the injury by
regulating certain plasticity-inducing factors. Operating under this notion, there are
several scenarios that one could use to explain these observations, 1) such factors could
be regulated in a manner meant to achieve the degree of homeostatic plasticity (aka
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“normalcy”) that was present in the circuitry before the injury 2) such factors could be
regulated based on the capacity for the circuitry to achieve a certain degree of
homeostatic plasticity(that is, based on severity of the injury and how well the animal(s)
recovered). If the former is the case, then one would expect that the further the animal is
from how it functioned before the injury (i.e. more severely injured), the more highly a
plasticity inducing molecule would have to be expressed to achieve the level of pre-injury
function. If the latter is the case, then one would expect essentially that the higher the
capacity for functional recovery (i.e. less severely injured), the higher the level of
expression of these plasticity-inducing factors.
It is important to note, that the “factors” being referred to could either be the
neurotrophins/Trks themselves and/or some other molecule that regulates expression of
all the neurotrophins/Trks. If it is a single neurotrophin, the prime candidate would be
NT3, as it is the only neurotrophin that has been shown to be able to bind to and activate
all three Trk receptors (Davies, Minichiello et al. 1995). If it is all the neurotrophins, then
it would likely be acting through the pan-neurotrophin receptor p75 (Dechant, RodriguezTebar et al. 1994). There is also the possibility that it is not the neurotrophins acting
through Trks or p75, but through a separate signaling mechanism that acts on all
subclasses of neurons in the DRG that express neurotrophins/Trks and accordingly
coordinates levels of expression, such as an inflammatory mediator. Indeed,
inflammatory molecules such as TNFalpha and IL6 have been suggested to be associated
with NGF (Woolf, Allchorne et al. 1997) and BDNF (Lin, Ro et al. 2011) mediated hyper
excitability of DRG neurons in models of neuropathic pain. The observation that CCL2 is
drastically upregulated at 12 weeks is particularly interesting, given that CCL2 can effect
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DRG neurons of all sizes (i.e. large, medium, small) (White, Sun et al. 2005), which
theoretically encompasses all subpopulations of neurons that express Trk receptors in the
DRG. Finally, these putative interactions could be occurring synergistically, such that an
external factor initiates a particular expression pattern which is then overtaken by
neurotrophin/Trk mediated neurotrophin/Trk expression in a feed-forward manner, or
vice versa.
Upon further analysis, by calculating the correlations between expression levels
of the different neurotrophins and Trks in the context of each individual animal, we were
able to uncover what appears to be a coordinated pattern of expression that exists among
the neurotrophins and Trk receptors in the DRG (but not spinal cord) at 12 weeks (but not
at 6 weeks) post injury. This pattern was independent of injury severity (i.e. expression
values were correlated between all molecules regardless of whether the injury was
12.5gcm or 25 gcm). Furthermore, we investigated expression of cytokines as potential
elements involved in the changes we observed, and identified elements that were
regulated in either a time(i.e. CCL2) or injury severity dependent (i.e. gp130) fashion.
Based on these assessments, future investigations into the cause(s) of initiation of these
mechanisms will be better informed as to what might or might not be a useful starting
point.
The finding that at 12 weeks there was a coordinated expression pattern in the
DRG that was independent of injury-severity while certain transcripts increase (i.e. TrkA)
from 6 to 12 weeks, but other transcripts decrease (i.e.TrkB), warrants further
clarification. Why is this happening? More specifically, what is causing a different
direction of change in one versus the other if they are eventually being regulated in an
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analogous manner in the different constituent subpopulations of neurons? One possibility
is that each set of neurotrophin/Trk receptor has an initial response to loss of descending
input/alteration of afferent input acutely (i.e. TrkB increases, TrkA decreases), from
which it is still “recovering” at 6 weeks, that by 12 weeks has been overtaken by a
differing response. Such a response could be activity- or factor-dependent (or both) in
such a way that modulates their expression in a manner that dictates when expression of
one of these molecules (neurotrophin, Trk) is relatively low/high in the DRG of a certain
animal, that the other molecules of their family (neurotrophin, Trk) is relatively low/high
as well. It is also possible that both are active at the same time, with a more robust
response that masks the effect of the other until the initial robust response becomes
inactive and thus the other becomes more apparent.
The coordinated expression pattern can also be understood as a predictive factor
that, given a set of data, one could deduce which animal expressed a certain level of a
neurotrophin/Trk based on the expression level of another neurotrophin/Trk. For
example, view the range of all injured animals at 12 weeks post injury and their TrkA
expression values as lying on a spectrum from low to high. When compared with the
highest value from NGF, BDNF, NT3, TrkB, and TrkC, the highest expression in 4 of 5
of these molecules are from the same animal as that for TrkA. Though it might be useful
for one to view the coordinated expression pattern in this way to aid conceptualization, it
is important to note that the predictive power of any given point is directly related to the
correlation coefficient between two sets of molecules, and since none of the coefficients
were 1, this is not an absolute predictor (as demonstrated above).
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Due to the finding that control levels of certain genes changed between 6 and 12
weeks, plots were constructed for display purposes and to identify any robust trend that
might have been occurring that our statistical analyses failed to elucidate. These analyses
failed to uncover any novel findings, but served to demonstrate that there was a higher
degree of variability in neurotrophin expression than Trk receptor expression (Fig 21 and
22). Subsequent power analysis was performed post-hoc to determine the ideal group size
based on the average means and variability for all neurotrophins and Trk receptor
transcripts assessed. These analyses revealed that had we used an n of 12 for all groups,
we would perhaps have also found changes between groups relative to both injury
severity and survival time in the following analyses: TrkC in the DRG, NT3 in the DRG,
TrkB in the DRG, TrkA in the spinal cord, and TrkA in the DRG.
Severalother factors that could have influenced the results we observed warrant
further consideration. For instance, as the animals that were used in this experiment were
all females, it is important to note that the potential role of the estrous cycle was not
investigated. (Baker and Hagg 2005) found that after spinal cord contusion, the stage of
the estrous cycle did not affect sensory axon degeneration, though neurotrophin levels
were not examined. Investigations of the role of estrous cycle on neurotrophin/Trk
receptor levels have been performed primarily in the hippocampus. In one study, it was
shown that TrkA fluctuates by as much as 16-fold during proestrous in reactive
astrocytes. This effect was not observed in rats that were ovariectomized, however with
reintroduction of estrogen, TrkA increased 12-fold (McCarthy, Barker-Gibb et al. 2002).
This increase in expression of TrkA is also observed in medial septum neurons, and for
levels of BDNF in the hippocampus, but not NGF (Gibbs 1998). Mutated BDNF can lead

56

to increased anxiety behavior, impaired memory, and increased expression of BDNF and
its receptor TrkB in the hippocampal formation, and also alters the fluctuation of protein
expression observed across the estrous cycle (Spencer, Waters et al. 2010). Additionally,
in the hippocampus of mice, TrkB is phosphorylated during high-estradiol states(i.e.
proestrus in females) than lower estradiol states(estrus and diestrus in females and males)
(Spencer-Segal, Waters et al. 2011), an increase that also is accompanied by a period of
greater hippocampal excitability (Scharfman, Mercurio et al. 2003). These studies
highlight 1) that different stages of the estrous cycle can lead to differential changes in
gene expression of neurotrophins 2) that different stages of the estrous cycle can alter
BDNF levels, which leads to changes both to the activity of individual neurons and
behavior of the animal. Despite these documented interactions, the exact contributions of
hormone levels and stages of the estrous cycle to our data are unclear.
Another consideration is activity levels of the animals before sacrifice.
Specifically, changes in the activity level could alter the induction of immediate early
genes, such as c-Fos. c-Fos has been used as a marker for many cellular processes,
including activity (Jasmin, Gogas et al. 1994), hormonal activation (Li, Hand et al. 1997),
as well as neurotrophin binding (Boyce, Park et al. 2012). Spinal cord injury can also
induce expression of immediate early genes. After a spinal cord crush injury, levels of
immediate early genes, cytokines, and neurotrophins show a sequential expression pattern
that differs with time. c-fos and c-Jun reach peak levels an hour after injury, persisting for
up to 6 hours; followed by cytokines TNFa and IL6 which reach their peak expression
levels around 3 hours, persisting up to 12 hours; and then the neurotrophins NT3 and
BDNF begin to be upregulated at 12 hours (Hayashi, Ueyama et al. 2000). Relating this
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to activity period after sacrifice, animals that were sacrificed earlier in the day (close to
the night, their period of highest activity), would be more likely to have increased c-Fos
(for example) levels relative to those sacrificed at later times in the day. From the study
above it appears that this induction of immediate early genes does not begin to affect
neurotrophin levels until around 9 hours after these genes reach their peak, thus
neurotrophin levels would likely be higher later in the day, assuming a direct link
between activity, immediate early gene expression, and neurotrophin expression. The fact
that the animals were sacrificed in a sequential manner throughout the day (from
approximately 10am to 5 pm) and that we still found consistently elevated expression
levels in some groups, it seems unlikely that these factors played a significant role in
influencing the data. Nevertheless, it certainly would have been useful to have some
measure of activity, and similar future studies should attempt to address these concerns.
Though the manipulation of expression of the neurotrophins and/or Trk receptors
might seem beneficial when viewed alone for purposes of cell survival, or alteration of
excitability of a certain population of cells, these studies also highlight an idea that has
not been explored thus far with regard to neurotrophins. Though neurotrophins/Trk
receptors have been largely been investigated under that assumption that they have
discrete functions on discrete populations of cells, it is also possible that manipulation of
any one component of their signaling or expression system could alter the others in a way
that could be maladaptive. Take for instance the effects of NT3, which has established
functions as potentiating the excitability of proprioceptive neurons in both the DRG and
spinal cord (Klein, Silos-Santiago et al. 1994). If one were to attempt to overexpress NT3
as a means of enhancing the excitability of this system, it could inadvertently lead to
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overexpression of NGF as well (Mendell, Albers et al. 1999), which has documented
effects of leading to hyperexcitability of nociceptive neurons (though NT3 can have antinociceptive properties (Shu XQ 1999) as well, thus may serve to mitigate this effect to an
extent). Conversely, reducing expression of NGF to ameliorate pain could lead to
unwanted effects on proprioceptive circuits. Accordingly, investigations that involve
neurotrophins/Trk receptors should take into account the effect that manipulation of one
component could have on all others, both through expression analysis and functionally.
Furthermore, as side effects are a common reason for cessation of many therapies, this is
also important with regard to clinical studies that involve neurotrophins.
Taken together, these findings point to what appears to be a set of overlapping
interactions that ultimately produce a coordinated transcriptional network. After a
contusive injury to the thoracic spinal cord, a degree of descending input to the lumbar
cord is lost based on the exact nature of the injury. These inputs are heterogeneous in
nature in terms of neurotransmitter content of the spared tracts, and the location in the
lumbar cord onto which the tracts synapse. Despite this heterogeneity, the resulting effect
of this loss of descending input is loss of function of the output of lumbar circuits (i.e.
lower motoneurons), and loss of molecular interactions between synapses of the
descending tracts and the axons/dendrites/synapses present in the lumbar cord. Likely at
play in the acute setting of the injury is the release of inflammatory/stress molecules from
the spared descending synapses that is due to their interaction with the still dynamic
molecular setting of the injury site. After time has passed and the cord has “adjusted” to
the different environment and dynamic events have ceased, it appears based on our work
that an external factor begins to regulate the expression of the neurotrophins and their
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cognate Trk receptors in a “coordinated” manner. Based on our results, CCL2 seems to
be a potential contributor to such a process, as it is dramatically upregulated at time
points when we see this phenomenon of coordinated expression (Fig 20) and has been
previously shown to effect large, medium, and small diameter cells of the DRG, which
represent all different subclasses of neurons on which Trk receptors are present (White,
Sun et al. 2005).
Though this is one mechanism that may be present, a separate mechanism,
perhaps one that is activity dependent also appears to regulate the levels of the
neurotrophins and the Trk receptors. Such an activity dependent mechanism could be
based on a level of activity that is determined by injury severity, i.e. motor neuron pools
with greater levels of spared descending input lead to more motor output which leads to a
greater level of basal activity in the DRG. Summarily, both activity dependent and
independent mechanisms could be at play simultaneously to achieve a spectrum of
expression levels. Alternatively, differing levels of motoneuron output could lead to
release of a common factor/molecule in the periphery that is motoneuron activity
dependent but not dependent on levels of afferent activity. Whether this process is
beneficial or maladaptive to the entire system depends on a variety of factors, including
(but not limited to); the relative contributions of each trophic factor to the overall activity
of the system, how much the expression level of one factor influences the other, and the
severity of the injury and what types of information are relays to more rostral levels of
the nervous system. These findings have an impact not only as novel discoveries, but
could also have implications for the utility of different therapeutic approaches used to
help patients with spinal cord injury. Ultimately, only further investigation into the
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precise mechanisms that govern such processes will determine their impact on future
scientific research.

61

Figure 1

Figure 1: In ASIA A/B patients (complete motor loss) and ASIA C/D patients
(incomplete motor loss) with body weight supported treadmill training (BWST), levels of
activation of motor neuron pools show drastic spatiotemporal changes when compared
with controls (healthy subjects)
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Figure 2

Figure 2: Treadmill training improves both maximum speed of stepping and the number
of successful steps that are able to be performed after thoracic transection in the cat.
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Figure 3

Figure 3: Contusive spinal cord injury results in decreased expression of BDNF, but does
not change NT3 expression. Exercise after contusive spinal cord injury results in levels of
BDNF and NT3 expression that are elevated relative to what is observed after contusive
spinal cord injury.
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Figure 4

Figure 4: Neurotrophic factor treatment(NTF) after thoracic transection of the cat spinal
cord produces the same effect as treadmill training(trained) after transection.
Combination of training and neurotrophic factor treatment results in similar kinematic
parameters as seen before transection.
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Figure 5

Figure 5: BDNF decreases the amplitude of the EPSP in motoneurons after afferent
stimulation. NT3 increases the amplitude of the EPSP in motoneurons after afferent
stimulation, demonstrating a difference in the effects of the two Trk receptor ligands.
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Figure 6. Injuries were characterized
using BBB scores to assess hindlimb
locomotor function and white matter
sparing (WMS) at epicenter using EC
stain. (A) BBB scores of groups that
received 12.5 g-cm (blue) or 25 g-cm
(green) NYU injuries. Starting at week
5, a significant difference was observed
between the two injury severities. Both
groups were significantly different
(p<0.05) from controls (not shown) at all
time points. (B) White matter sparing at
epicenter (x-axis) plotted versus BBB
score. Black dots represent 6 week
values. Green dots represent 12 week, 25
g-cm injured animals. Blue x represent
the two animals from the 12 week, 12.5
g-cm group with the lowest BBB scores within the group. Blue dots represent the four
animals from the 12 week, 12.5 g-cm group with the highest BBB scores within the
group. (C) Image taken from a 12.5 g-cm contused animal showing a laterallysymmetrical injury pattern at the epicenter. Note the difference from (D), which was
taken from an animal that also received a 12.5 g-cm spinal cord contusion but which
yielded an asymmetrical injury at epicenter. *p<0.05, ***p<0.001
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Figure 7.

mRNA expression of Trk receptors is altered in L4/5 DRG at 6 and 12 weeks after
receiving either 12.5 g-cm(blue) or 25 g-cm(green) NYU contusion injury to spinal cord
at vertebral level T9. Fold change (F.C.) is reported as change of 12 week relative to 6
week time points in all figures. Black bar on TrkA reports fold-change (f.c.) of 25 g-cm
at 12 weeks relative to 12.5 g-cm at 12 weeks. X axis denotes weeks post injury. White
lines in box-plots indicate group mean. Dotted gray lines indicate expression level of
controls (normalized to 1), with ± s.e.m. indicated by the vertical arrows at right end of
the control line. #p<0.05 vs. control, *p<0.05, **p<0.01, ***p<0.001
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Figure 8

mRNA expression of Neurotrophins is altered in L4/5 DRG at 6 and 12 weeks after
receiving either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord
at vertebral level T9. Fold-change (f.c.) is reported as change of 12 week relative to 6
week time points in all figures. X axis denotes weeks post injury. White lines in boxplots indicate group mean. Dotted gray lines indicate expression level of controls
(normalized to 1), with ± s.e.m. indicated by the vertical arrows at right end of the control
line. #p<0.05 from control. *p<0.05, **p<0.01, ***p<0.001
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Figure 9.

mRNA expression of Trk receptors is altered in L4/5 spinal cord at 6 and 12 weeks after
receiving either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord
at vertebral level T9. Fold-change (f.c.) is reported as change of 12 week relative to 6
week time points in all figures. X axis denotes weeks post injury. White lines in boxplots indicate group mean. Dotted gray lines indicate expression level of controls
(normalized to 1), with ± s.e.m. indicated by the vertical arrows at right end of the control
line. #p<0.05 from control. *p<0.05, **p<0.01, ***p<0.001
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Figure 10.

A) Scatterplots of Neurotrophin mRNA expression in L4/5 SC at 6 and 12 weeks after
receiving either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord
at vertebral level T9, relative to the unified control group as was done for the other data.
x's represent mRNA expression of age-matched naive animals. Open circles represent
expression of age-matched laminectomy control animals. *p<0.05, **p<0.01
B) mRNA expression of Neurotrophins in L4/5 SC at 6 and 12 weeks after receiving
either 12.5 g-cm (blue) or 25 g-cm (green) NYU contusion injury to spinal cord at
vertebral level T9, relative to their respective age matched control groups. X axis
denotes weeks post injury. White lines in box-plots indicate group mean. Dotted gray
lines indicate expression level of controls (normalized to 1), with ± s.e.m. indicated by
the vertical arrows to the right of each time-point pair. #p<0.05 from control.
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Figure 11: NGF expression as a function of age in the L4/5 spinal cord of naïve rats

Figure 11: No age-related change in mRNA expression of NGF.
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Figure 12: BDNF expression as a function of age in L4/5 spinal cord of naïve rats

Figure 12: No change in age-related expression of BDNF.
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Figure 13: NT3 expression as a function of age in L4/5 spinal cord of naïve rats

Figure 13: NT3 expression is elevated at 9 months post birth relative to both 3 and 6
months post birth. *p<0.05. **p<0.01
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Figure 14.

Figure 14: Correlated expression of neurotrophins in DRG emerges at chronic time
points. Blue dots represent animals with 12.5 g-cm injuries. Green dots represent
animals with 25 g-cm injuries. Values represent fold-change of the individual animals
versus mean of control group.
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Figure 15.

Figure 15: Correlated expression of Trk receptors in DRG emerges at chronic time points.
Values represent fold-change of the individual animals versus mean of control group.
Blue dots represent animals with 12.5 g-cm injuries. Green dots represent animals with
25 g-cm injuries.
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Figure 16

Figure 16: No change was observed between any injury severity or time point in the DRG
for LIF or CD11b expression.
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Figure 17

Figure 17: No change was observed between any injury severity or time point in the DRG
or spinal cord in TNFa expression
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Figure 18

Figure 18: GP130 is decreased in 25 g-cm injury severity group at both time points
relative to 12 weeks 12.5 g-cm injury severity group. *p<0.05. ***p<0.001. ##p<0.01 vs
control group.
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Figure 19

Figure 19: CNTF expression increases at 12 weeks in both injury severities. Control
group at 12 weeks time point also increases(top). Relative to time matched control,
CNTF expression is increased at 6 weeks in the 25 g-cm injury severity, no change
relative to 12 week time matched control. Black bar represents mRNA expression of
control group. Blue bar represents mRNA expression of 12.5g-cm injury severity group.
Green bar indicates mRNA expression of 25 g-cm injury severity group.
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Figure 20

Figure 20: CCL2 expression increases at 12 weeks post contusive spinal cord injury.
Black bars represent mRNA expression of control group. Blue bars represent mRNA
expression of 12.5 g-cm injury severity group. Green bars represent mRNA expression of
25 g-cm injury severity group. **p<0.01
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Figure 21

Figure 21. Control expression values of all groups assessed for mRNA levels of
neurotrophins and Trk receptors in the DRG. An initial statistical analysis(t-test) was
performed to determine if an age dependent change existed between our 6 and 12 week
control groups. After performing this analysis we determined that no age related changes
existed for our expression values in the DRG. Thus, all control relative expression values
were combined, averaged, and then normalized to the combined average of all control
values for each molecule labeled on the x-axis (denoted as f.c. all control on y-axis). Red
X: 12 week control expression values. Black dot: 6 week control expression values.
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Figure 22

Figure 22. Control expression values of all groups assessed for mRNA levels of
neurotrophins and Trk receptors in the spinal cord. An initial statistical analysis(t-test)
was performed to determine if an age dependent change existed between our 6 and 12
week control groups. After performing this analysis we determined that no age related
changes existed for our Trk receptor expression values in the spinal cord, but an apparent
age related change in controls did exist for the neurotrophins in the spinal cord. All
control relative expression values were combined, averaged, and then normalized to the
combined average of all control values for each molecule labeled on the x-axis (denoted
as f.c. all control on y-axis) Due to the difference observed for neurotrophin expression
values in controls, further analysis was also performed relative to expression values of
time matched controls at 6 and 12 week time points (Figure 10). Red X: 12 week control
expression values. Black dot: 6 week control expression values. *p<0.05
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Table 1. Summary table of previous findings for NTs and Trk. (Hougland et al 2012)
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Table 1(continued)
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Table 1(continued)
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Table 1(continued)
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Table 2. Correlations between expression of mRNA for trk receptors in spinal cord.

TrkA vs TrkB
TrkA vs TrkC
TrkB vs TrkC

Control
6 week
12 week
r‐value p‐value r‐value p‐value r‐value p‐value
0.47
0.2
0.25
0.46
0.19
0.56
0.42
0.26
0.21
0.53
0.4
0.19
0.75
0.01
0.76
0.004
0.44
0.16
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Table 3. Correlations between expression of mRNA for neurotrophins, Trk receptors,
and cognate pairs.

Control
6 week
r‐value p‐value r‐value p‐value
NGF vs BDNF 0.20
0.61
0.15
0.69
NGF vs NT3
0.72
0.03
0.87
0.003
BDNF vs NT3
0.10
0.80
0.33
0.38
TrkA vs TrkB
0.04
0.90
0.005
0.989
TrkA vs TrkC
0.56
0.11
0.61
0.08
TrkB vs TrkC
0.40
0.28
0.38
0.31
NGF vs TrkA
0.65
0.06
0.55
0.13
BDNF vs TrkB 0.45
0.22
0.69
0.04
NT3 vs TrkC
0.57
0.11
0.61
0.08
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12 week
r‐value p‐value
0.84
0.001
0.92
0.00006
0.88
0.0004
0.89
0.0007
0.79
0.006
0.78
0.004
0.88
0.0004
0.77
0.005
0.77
0.006

Table 4. Transcription factor binding sites for neurotrophin and trk receptor genes.
TF Binding-s ite nam e
AhR
AhR:Arnt
AP-1
AP-2
AR
Arnt
ATF
ATF2
ATF2:cJun
Brn-2
C/EBP
CAR
c-Ets-2
c-Jun
c-Myc:Max
COUP-TF1
CREB
CREB,ATF
CREM
DEC
E2A
Ebox
ER-alpha
Ets
Foxj1
FOXO1
GATA-3
GR
HES1
HOXA5
HOXB8
KROX
MAF
MAFB
Max
MEF-2
MEF-2C
Myc
Neuro D
NFAT1
NF-AT4
NF-kappaB
NKX2B
NRSF
NURR1
Oct-1
Octamer
Oct-x
p53
Pax-3
Pax-6
Pax-8
Pbx1
POU6F1
POUF2F1
PPARgamma
PPARgamma:RXR-alpha
PXR
RXR-alpha
SF1
SMAD
Smad3
Sox1
Sox2
Sp1
SRF
Sry
STAT
STAT1
STAT3
Tax
Tax/CREB
Tbp
TCF-4
Tcf ap2a
Tcf ap2b
Tst-1
USF
USF2
VDR
VDR, CAR, PXR

HGNC s ym bol
AHR
FOS; FOSB; JUN; JUND
TFAP2A
AR
ARNT
ATF
ATF2
POU3F2
CEBPA,B,D,E,G,Z
NR1I3
ETS2
JUN
NR2F1
CREB1
CREM
BHLHE40
TCF3
TCF3; MYOD1; MYOG
ESR1
ETS1,2; ETV1,2,3,4,5,6,7
FOXJ1
FOXO1
GATA3
NR3C1
HES1
HOXA5
HOXB8
EGR1,2; ZNF22; ZBTB7B
MAF
MAFB
MAX
MEF2A
MEF2C
MYC
NEUROD1
NFATC2
NFATC3
NFKB1
NKX2-2
REST
NR4A2
POU2F1
POU f amily of proteins
STAT1
TP53
PAX3
PAX6
PAX8
PBX1
POU2F1
POU6F1
PPARG
NR1I2
RXRA
SF1
MADH f amily of proteins
SMAD3
SOX1
SOX2
SP1
SRF
SRY
SOAT1
STAT1
STAT3
CNTN2
TBP
TCF4
TFAP2A
TFAP2B
CCDC6
USF1
USF2
VDR

Trk A NGF
x

x

x
x

x
x

x
x

Trk B BDNF
x
x
x
x
x
x
x
x
x
x
x
x

Trk C NTF3

x
x

x
x
x
x
x

x

x

x
x

x
x

x

x

x
x
x

x
x

x
x
x
x
x
x

x

x

x
x

x
x

x
x
x
x
x
x

x
x

x
x

x
x
x
x

x

x

x
x

x
x
x
x

x
x
x
x
x
x
x
x
x
x

x

x
x
x
x
x

x

x

x

x
x
x

x
x

x

x
x
x

x

x
x

x
x
x
x

x
x
x

x
x
x

x
x
x
x
x

x

x
x
x
x
x
x
x

x
x
x
x

x
x
x
x

x

x

x
x

x
x

x
x
x

x
x

x
x

x
x
x
x
x
x
x
x
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x

Entries with
transcription
factors separated
with a “:” have
binding sites
situated such that
they act in a
cooperative
fashion, rather
than independent
from each other.
Entries with
transcription
factors separated
by a “,”share
binding sites or
have binding sites
situated near each
other such that
the factors act in
competition with
each other.
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